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Abstract: 
Objective: Bioactive silicate glass-based Perioglas® has been used to treat 
periodontal-bony-defects. During glass degradation in body fluids, this glass 
generates a high pH>8. This high pH may enhance the growth of periodontopathic 
bacteria such as P.gingivalis which grows optimally at a pH ≈ 8.3. Furthermore, the 
high pH is likely to inhibit osteoblast activity, resulting in suppression of osteogenic 
differentiation/proliferation in the local biological environment. Therefore, this work 
aims to develop novel strontium-containing silicate/phosphate glass-mixtures where 
the phosphate glass generates an acidic pH to offset the alkaline pH arising from 
the silicate bioactive glass. The objective is being to (i) inhibit the alkaline 
periodontal bacterial growth of virulent P.gingivalis and (ii) create a neutral 
periodontal environment for osteoconductive bone regeneration. Strontium is known 
to stimulate osteoblasts and has a bactericidal action against P.gingivalis, it also 
provides radio-opacity enabling the dissolution process to be potentially followed 
clinically by X-rays. 
 
Methods: Nine compositions of bioactive silicate/phosphate glass-mixtures were 
prepared. The glasses synthesised were ground and sieved to obtain a specific 
selection of particle size fractions for glass-mixtures preparation. The glass-
bioactivity was performed by immersing the prepared glass mixtures in Tris, SBF 
and ALP containing Tris buffer solution. The pH change in solutions was measured 
and the ions release was quantified by ICP-OES as a function of time. The glass-
mixtures degradation and apatite formation were investigated by Infrared-
Spectroscopy-FTIR, MAS-NMR Spectroscopy and Solution-NMR Spectroscopy. 
 
Results: The pH behaviour was modulated by immersing the nine compositions of 
glass-mixtures in buffers solution. The degradation of glass mixtures in Tris buffer 
was evaluated by MAS-NMR and revealed the transformation of the Q2 
metaphosphate species into large amounts of Q1 species with a small amount of Q0 
orthophosphate species. The rate of these transformations of glass mixtures 
depends on the mixture composition (the ratio of silicate glass to phosphate glass). 
ALP which is elevated in periodontal bony defects hydrolysed the terminal 
phosphate Q1 species of the Q2-metaphosphate chain of phosphate glass and 
converted it into Q0-orthophosphate species as demonstrated efficiently by Solid 
and Solution NMR spectroscopies. 
 
Conclusion: Smart modulation of pH profile was essential to inhibit the alkaline 
bacterial growth of P.gingivalis. The transformation of Q2-metaphosphate species 
into Q1-species demonstrated by spectroscopy was significant finding as the 
emerging Q1-species was hydrolysed by ALP enabling hydroxyapatite precipitation 
for new bone formation. This extremely pioneering technology of mixing phosphate 
and silicate glasses and using them with ALP has potential for the development of 
new biomedical materials for different applications. 
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Generally, periodontal diseases are classified according to the severity of the 
disease. The two major stages are gingivitis and periodontitis. Gingivitis is a milder 
and reversible form of periodontal disease that only affects the gingiva. Gingivitis 
may however, lead to more serious, destructive forms of periodontal disease called 
periodontitis. 
Periodontitis has been defined as "an infectious disease resulting in inflammation 
within the supporting tissues of the teeth, progressive attachment loss and bone 
loss" (Newman et al., 2011). As a consequence, it can be suggested that the main 
clinical and aetiological characteristic features of periodontitis are:  
1. supragingival and subgingival bacterial plaque accumulation which in turn 
may lead to calculus formation;  
2. gingival inflammation and pocket formation;  
3. attachment loss and alveolar bone resorption; 
4. in severe cases, spontaneous gingival bleeding, tooth mobility and loss of 
the teeth (Newman et al., 2011).  
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Figure ‎1.1 Showing periodontitis with deep pocketing, loss of attachment and alveolar 
bone resorption (Whitney, 2018). 
 
Carranza and Newman (Newman et al., 2011) cited some of the potential risk 
factors which have been associated with the risk of developing periodontal 
diseases, which can also be classified as systemic and local factors as listed below: 
 Tobacco smoking (environmental factor); 
 Systemic diseases such as diabetes; 
 Some types of medications such as steroids, some types of anti-epilepsy 
drugs, cancer therapy drugs, some calcium channel blockers; 
 Pathogenic bacteria such as Actinobacillus actinomycetemcomitans (Aa) 
and Porphyromonas gingivalis (Pg); 
 Psychological factors e.g. stress; 
 Bridges that no longer fit properly (local factor); 
 Anatomical factor e.g. crooked teeth (local factor); 
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 Defective restorations (with overhangs affecting the gingival crevice) (local 
factor); 
 Hormonal changes associated with pregnancy or use of oral contraceptives. 
1.1.1 Periodontal Pocket: 
 
A periodontal pocket may be classified as follows: 
1) Gingival pocket: known as pseudo-pocket or false pocket which is formed by 
gingival overgrowth without any associated destruction of the alveolar bone tissues. 
2) Periodontal pocket: this type of pocket occurs with the destruction of the 
underlying alveolar bone tissues. Mobility of the teeth may also occur as a result of 
extensive periodontal ligament disruption and bone loss (Figure 1.2) (Newman et 
al., 2011). 
 
Figure ‎1.2 X-ray photograph showing bone resorption associated with chronic 
periodontitis. Taken from (https://areteethbones.com). 
 
Bone Loss 
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Furthermore, a periodontal pocket can be classified according to its distinguishable 
features into two types (Newman et al., 2011): 
1) A supra-bony pocket in which, the base of the pocket is coronal to the level of the 
underlying alveolar bone and the pattern of bone loss is horizontal. 
2) An infra-bony pocket, where the base of the pocket is apical to the adjacent bone 
so that the bone is juxtaposed to the soft tissue wall and the model of bone 
destruction is vertical (angular). This is depicted in Figure (1.3). 
 
Figure ‎1.3 Demonstrating the different types of periodontal pockets (Newman et al., 
2011). 
 
In addition, an infra-bony pocket can be classified according to the number of 
residual bony walls into one-wall, two-wall and three-wall defects as illustrated in 
Figure 1.4. 
Page | 21  
 
The morphology of infra-bony defects has a significant influence on the periodontal 
regenerative process. Some studies have demonstrated the intimate relationship 
between the depth and width of the infra-bony defects and the outcome of both the 
clinical attachment and bone repair following one year of periodontal treatment. In 
other words, the greater outcome of the improved clinical attachment was strongly 
related to the deeper defect, whereas the lower clinical attachment and bone repair 
were attributed to the wider defect (Garrett et al., 1988, Tonetti et al., 1993, Tonetti 
et al., 1996). 
 
Figure ‎1.4 Infra-bony defects. (a) Three-wall infra-bony defect. (b) Two-wall infra-bony 
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1.1.2 Pathogenic Bacteria of Periodontal Diseases: 
 
The term ‘keystone pathogen’ can be described and defined in the field of microbial 
ecology as an architecture of microbial communities and their interaction with the 
living host tissues. Keystone pathogens refer to crucial keystone microorganisms 
that initiate and enhance microbiota associated with disease status. In periodontitis, 
periodontal pathogens such as Porphyromonas gingivalis (P. gingivalis) impair the 
normal homeostatic host-microbial interplay causing subversion of the host immune 
system strategies (Hajishengallis et al., 2012).  
In the field of molecular biology, most pathogenic microorganisms have the ability to 
adhere either to the soft tissue surfaces such as mucosa and epithelium or the hard 
tissue surfaces such as teeth/bone, as well as artificial surfaces in the form of 
dentures and implants. This bacterial adhesion to its host cells can be regarded as a 
crucial trigger for the induction of periodontal infections, such as gingivitis or 
periodontitis. One of the periodontopathogens namely P. gingivalis has an extensive 
battery of virulence factors for the progression of periodontal diseases (Newman et 
al., 2011). According to Newman et al. 2011, the proposed strategy upon which 
these virulence factors contribute to develop periodontal diseases is as following: 
(1) By promoting bacterial growth and colonization (adhesins) to host cells such 
as in the pocket epithelium. 
(2) Destruction of the host tissues by bacterial proteinases and toxins.  
(3) Protection of pathogenic bacteria against the defence response of the host 
tissues. 
It has been reported that the pH of the normal gingival crevice is below neutrality in 
healthy periodontal tissues (McDermid et al., 1988). During the development of the 
periodontal pocket via the process of pathogenesis of periodontal diseases (which 
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includes the apical migration of the junctional epithelium, subsequent attachment 
loss of fibres, destruction of connective tissues and alveolar bone resorption). The 
normal gingival crevice transforms into a pocket and the pH increases to above pH 
8 which favours the conditions that promote the progression of the disease process 
(McDermid et al., 1988). Therefore, in a deeper periodontal pocket, the pH may be 
as high as 9 as reported by the Bickel & Cimasoni study (Bickel and Cimasoni, 
1985). This change in the local pH of the developing pocket has a significant effect 
on the growth and enzyme activity of the bacteria present in periodontal pockets 
such as P. gingivalis.  
P. gingivalis is a gram-negative, non-motile, acid-sensitive and anaerobic bacterium, 
it plays an active and key role in the development and progression of periodontal 
diseases. It has been reported that P. gingivalis inhabits the alkaline environment of 
subgingival sites (periodontal pockets) where the “optimum pH for P. gingivalis 
growth is approximately 8” (Nakayama, 2015).  
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1.1.3 ALP in Periodontal Degeneration and Regeneration: 
 
Typically, a correct diagnosis of periodontal disease depends on the collection of 
data from the periodontal patients’ examination and subsequent charting of the 
information as indicated below. The clinical examination is supplemented by taking 
a thorough medical and dental history to determine whether genetic, environmental 
(such as smoking), systemic conditions (such as diabetes), concomitant medication, 
stress, obesity may affect the extent and severity of periodontal disease (so-called 
risk factors and indicators). Traditionally, the severity of the individual patient’s 
periodontal status can be identified and quantified by conventional periodontal 
diagnostic clinical parameters such as measurement of pocket depth, gingival index, 
plaque index, loss of attachment apparatus and radiographic analysis of alveolar 
bone resorption (Armitage, 2004). However, these classic diagnostic tools have 
limitations since they can only provide the clinicians with a previous history of the 
periodontal status e.g. radiographic bone loss, but not the current periodontal status 
to be evaluated. Recently, advanced diagnostic procedures based on biochemical 
markers have been developed for the early detection of an individual’s periodontal 
risk assessment.  
Through the area of both the periodontium and gingival crevice, the inflammatory 
process of periodontal pathogenesis occurs as a host response to plaque bacteria 
biofilms. This process leads to the release of some enzymes from the injured 
periodontal tissues into the gingival crevicular fluid (GCF) and saliva. Among these 
released enzymes are “alanine aminotransferases, lactate dehydrogenase, gamma-
glutamyl transferase, creatine kinase, alkaline phosphatase, and acid phosphatase” 
(Sanikop et al., 2012).  
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The biochemical marker ALP was detected in dental plaque biofilm, gingival 
crevicular fluid (GCF), and collected saliva (Sanikop et al., 2012). ALP has gained 
attention in periodontal research as a potential novel biotechnology for diagnosis, 
prognosis periodontal therapy, and drug innovations as elucidated in Figure 1.5. 
  




Figure ‎1.5 Futuristic chairside diagnostic test based on GCF sampling. Considering 
the GCF fluid as a potential analyte for the screening of multiple biomarkers, a rapid, 
chairside‎diagnostic‎ tool‎ (represented‎ in‎ the‎Figure‎as‎a‎Micro‎Analyser)‎or‎a‎“mini-
lab”‎ could‎ be‎ used‎ by‎ clinicians‎ for‎ risk‎ assessment‎ and‎ decision‎ making on 
treatment planning. The advantages of such a tool would be enhanced predictability 
of clinical outcomes and well-informed patients regarding personalized treatment 
needs. As shown, a simple clinical procedure for GCF collection could be used, 
followed by extraction of analytes from the test strip. The fluid present on the test 
strip would be subjected to volumetric quantification. After an elution procedure to 
“wash”‎and‎retrieve‎the‎compounds‎from‎the‎fluid,‎the‎sample‎would‎be‎analyzed.‎An‎
immediate comprehensive risk report profile and biomarkers screening would enable 
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Alkaline phosphatase (ALP) refers to a “calcium- and phosphate-binding protein and 
a phospho-hydrolytic enzyme” (Sanikop et al., 2012). It can also be defined as a 
“membrane-bound glycoprotein produced by cells such as polymorphonuclear 
leukocytes (PMNLs), osteoblasts, macrophages, and fibroblasts within the area of 
the periodontium and gingival crevice”(Daltaban et al., 2006). 
ALP has the unique feature of being involved both in pathogenic processes as well 
as in bone regenerative processes (Groeneveld et al., 1996). It has been identified 
in gingival crevicular fluid (GCF), saliva and dental plaque bacteria. Increased levels 
of ALP is associated with the progression of periodontal disease from the healthy 
periodontium to a chronic periodontitis status indicate that this enzyme may be of 
diagnostic value in the diagnosis of periodontal diseases or at the very least a 
monitor of decreased/increased activity during periodontal treatment. The direct 
relationship between the elevated level of ALP and the severity of the periodontal 
disease can be observed in Table 1.1. This table demonstrates how high the actual 
value of ALP levels can be when comparing to healthy periodontal condition, 
gingivitis and chronic periodontitis with other traditional clinical parameters, 
including probing depth and attachment level. These clinical conditions correlate 
strongly with the recorded ALP concentrations. Figure 1.6 also records the 
relationship between the ALP levels in GCF and the three periodontal groups 
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Table ‎1.1 Showing the correlation of the mean ALP levels with the various clinical 
parameters in the three groups of periodontal status: (healthy, gingivitis and chronic 





















Mean ± SD 
Gingival 
index 
Mean ± SD 
Plaque 
index 




Mean ± SD 
Clinical 
attachment 
Level (in mm) 
Mean ± SD 
Healthy 170 ± 70 0.00 0.46 ± 0.6 1.26 ± 0.5 1.40 ± 0.5 
Gingivitis 271 ± 11 2.13 ± 0.6 2.73 ± 0.5 2.20 ± 0.7 1.93 ± 0.7 
Chronic‎
Periodontitis 
732 ± 42 2.40 ± 0.7 2.46 ± 0.5 6.13 ± 1.5 7.07 ± 1.4 
‎‎‎‎‎ALP-Alkaline‎Phosphatase,‎SD-Standard‎Deviation 
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Interestingly, ALP stimulates new bone remineralisation due to its activity to 
hydrolyse the Q1-pyrophosphate species (inhibitor of bone mineralisation) into Q0-
orthophosphate species (Grover et al., 2013), providing local supersaturation of the 
biological environment with high levels of phosphate and calcium ions. This activity 
results in hydroxyapatite precipitation which is essential for new bone formation as 











Figure ‎1.7 Schematic diagram demonstrating the ability of ALP enzyme to extract the 
orthophosphate species from the pyrophosphate species.   
 
However, the enzyme kinetics may be influenced by pH changes (Bisswanger, 
2017). For example, the bell-shaped pH curve can elucidate the dependence of the 
tested enzyme activity on the pH value as demonstrated in Figure 1.8 (Bisswanger, 
2014). This activity is ascending from zero (area of strong acidity) up to an optimum 
pH, then the reading is descending to zero again (area of strong alkalinity). 
The maximum value of pH in the bell-shaped pH curve is the pH optimum; this value 
represents the maximum enzyme activity (Vmax) which can be employed as a 
criterion of pH standardisation through enzymatic kinetics studies. Predominately, 
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however, each enzyme has an optimum pH, at which it shows different maximum 
activity. For instance, the pH optimum of protease stomach enzyme is 2, acid 
phosphatase with pH 5.7 and with the alkaline phosphatase pH 10.5 (Bisswanger, 
2014). Therefore, the enzymatic sensitivity must be investigated under the individual 
enzyme special pH maximum. 
 
Figure ‎1.8 pH optimum curve for the activity of an enzyme (black). The pH of the 
maximum is the pH optimum. The green area shows the physiological range. The red 
line shows the broader pH stability curve of the enzyme (Bisswanger, 2014). 
 
 
A study was undertaken by Flynn et al. (Flynn et al., 2002), where the investigators 
studied the influence of pH levels on the intestinal mucosa alkaline phosphatase 
(ALP) activity. The investigators reported a positive correlation between pH values 
and the ALP activity. This effect has been attributed to the presence of ionisable 
groups within the active site of the enzyme. Flynn and his co-authors reported that 
optimum ALP enzyme activity (Vmax) was elevated with both increased ALP 
concentrations (Km) and increased pH levels as indicated in Table 1.2:  
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Table ‎1.2 Displaying both Vmax and Km of Alkaline phosphatase at different pH 
measurements (Flynn et al., 2002). 
 
 
Moreover, Flynn and his colleagues studied the behaviour of the ALP catalytic 
activity with various artificial substrate concentrations of p-nitrophenol phosphate 
(pNPP) at different pH values. They reported that the enzyme catalysis increased 
up to a three-fold value with increasing concentrations of the substrate (pNPP) 
within a pH range from 7 to 9 as expressed in Figure 1.9 (Flynn et al., 2002). 
However, a dramatic increase in the enzymatic activity was distinct from shifting pH 
7.0 to 7.5 and from 8.5 to 9.0, whereas the pH readings between the two values 
were slightly deviated.  
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Figure ‎1.9 The effect of pH on the enzymatic activity of alkaline phosphatase under 
different concentrations of substrate pNPP (Flynn et al., 2002). 
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1.2 Biomaterials used in Periodontology: 
 
According to Williams (1999), bioactive materials can be defined as “materials that 
have the ability to dissolve in physiological body fluids, forming a chemical bond 
between the glass and host tissues”. 
Over the last two to three decades, the main goal in periodontal treatment was to 
regenerate the damaged periodontium with therapeutic approaches based on a 
scientific rationale to initiate, replace and encourage cells that were regenerating the 
lost tissue structure such as periodontal ligament cells. A variety of biomaterials 
have been developed for the application of both periodontal tissue regeneration and 
osseo-integration procedures in the defect site. These include materials such as 
barrier membrane, growth factors, bone graft material and combined procedures as 
indicated in the Tables below 1.3, 1.4 and 1.5:  
Table ‎1.3 Types of barrier membrane used in periodontal treatment (Cho et al., 2017). 
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Table ‎1.4 Types of bone graft materials used in periodontal regeneration procedures 
(Cho et al., 2017). 
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Table ‎1.5 Showing a summary of growth factors used in periodontal regeneration 
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1.2.1 Properties of an Ideal Bone Graft Material: 
 
Currently in dentistry there are significant clinical challenges associated with the 
replacement of severe localized bone loss from periodontal disease. For this 
reason, a variety of materials and techniques have been developed to enable 
surgeons to address this problem, each of these materials having both advantages 
and disadvantages. However, four characteristic features are desirable when 
developing a valuable mainstream bone graft material and these include: 
(i) Osseointegration: is the ability to form a chemical bond with the surface of the 
bone without any interference of fibrous tissue encapsulation (Costantino and 
Friedman, 1994);  
(ii) Osteogenesis: is the process by which osteoblasts that exist in the grafting 
material are able to form bone into the surgical site (Cypher and Grossman, 1996). 
Autogenous iliac bone and marrow grafts are optimal examples of these materials;  
(iii) Osteoconduction: is the characteristic of a grafting material to enhance bone 
apposition from existing living bone and this process necessitates the availability of 
differentiated mesenchymal cells. A grafting material is osteoconductive when it 
provides a scaffold suitable for the apposition of new bone. Hydroxyapatite is an 
example of osteoconductive graft;  
(iv) Osteoinduction: is the ability of a grafting material to stimulate the transformation 
of the undifferentiated pre-osteoblast into a viable osteoblast; thereby enabling the 
newly osteoid tissue to be deposited and mineralised. This mechanism is mediated 
by a specific type of protein, such as bone morphogenic proteins (BMPs) 
(Ogunsalu, 2011).  
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1.2.2 Classification of Current Bone Graft Materials: 
 
(i) Autografts: these materials exhibit osteogenic, osteoconductive and 
osteoinductive properties. Limitations have been attributed to the longer operative 
time, lack of availability, serious morbidity related to blood loss, localized loss of 
sensation, wound complications and donor site chronic pain (Kurz et al., 1989); 
(ii) Allografts: these are non-vital grafting material (tissue) transferable from one 
individual to another of the same species. They possess osteoconductive but poor 
osteoinductive properties, their main beneficial advantages include greater 
availability in hospital bone banks as well as removing the requirement for surgical 
intervention from the donor site. However, their disadvantages are associated with a 
potential risk of disease transmission, exclusion of osteogenic features, variable 
clinical outcomes and high cost; 
(iii) Xenografts: which are materials (tissues) shared between different species. 
Xenografts exhibit osteoconductive, good availability and have no risk of disease 
transmission (Dumitrescu, 2011). In dentistry, xenografts applied as a bone graft are 
currently obtainable in three sources: bovine bone, equine bone and natural coral or 
algae. 
(iv) Synthetic Bone Graft: a miscellaneous artificial bone graft material has been 
engineered during the past 30 years with the aim to restore bone voids. Mostly 
these materials provide only two out of four properties for an ideal bone graft 
material. These are osteointegration and osteoconduction properties respectively. 
Optimally, synthetic bone graft substitutes should mimic the native bone in both 
mechanical and osteogenic properties. 
In terms of mechanical properties, the compressive strength of a synthetic bone 
graft substitute should be identical to the cortical/cancellous bone that is being 
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replaced. To approach this requirement, a similar modulus of elasticity to that of 
natural bone should be acknowledged to avoid any stress shielding in addition to 
keeping sufficient toughness against fatigue fracture under overloading.  
Based on Ashman (1992) an “ideal artificial bone graft material should demonstrate 
the following properties indicated below: 
1) Biocompatible (no inflammatory tissue reactions); 
2) Able to serve as a framework for new bone formation; 
3) Resorbable in the long term and have potential for replacement by the host 
bone; 
4) Osteogenic, or at least facilitate new bone formation; 
5) Radiopaque; 
6) Easy to manipulate clinically; 
7) Not support the growth of oral pathogens; 
8) Hydrophilic; 
9) Available in particulate and moulded forms; 
10) Have surface electrical charge (i.e., be charged negatively); 
11) Microporous and provide added strength to the regenerating host bone 
matrix, and permit biological fixation; 
12) Readily available; 
13) Non allergenic; 
14) Adapt to be effective in a broad range of medical situations (e.g., cancer, 
trauma and infective bone destroying diseases)”(Ashman, 1992); 
15) Have a surface that is amenable to grafting; 
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16) Act as a matrix or vehicle for other materials (e.g., bone protein inducers, 
antibiotics and steroids); 
17) Have a compressive strength comparable to cancellous bone (Ashman, 
1992). 
A variety of alloplastic synthetic grafts materials have been used to replace bone 
defects such as bioactive glass (Bioglass®45S5), β-tricalcium phosphate, synthetic 
hydroxyapatite and calcium phosphate cements (Moore et al., 2001).  
Finally, the optimal bone grafting material should be substituted by new bone 
deposition during the physiological stages of bone remodelling. However, the key 
determinant factors such as material type, structural features, pH and processing of 
the material play a significant role in determination the speed of biomaterial 
resorption and also the type of cells involved in this process (Legeros, 1993). 
Ideally, the graft resorption rate should be identical with the rate of bone formation; 
otherwise, faster resorption of graft material may produce gaps in the bony defects 
having an imbalance with bone apposition. Meanwhile, a slower resorption rate of 
the implanted material might suppress bone formation and increase fibrous tissue 
encapsulation. 
1.2.3 Periodontal Guided Tissue Regeneration (GTR): 
 
Guided tissue regeneration (GTR) is one of the procedures used for the treatment 
periodontal bony defects. Through this procedure, different types of barriers 
(membranes) have been placed in the surgical site of periodontal bony defect to 
separate the alveolar bone and periodontal ligament from the gingival epithelium 
and connective tissues (Sheikh et al., 2014). The advantage of GTR is to prevent 
the migration of the epithelium and the gingival connective tissue to the root surface 
during periodontal healing process. Thereby, the repopulation of the attachment 
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loss in periodontal bony defect is regenerated only by the cells from the periodontal 
ligament and bone tissue cells. The GTR technique is demonstrated in Figure 1.10. 
PerioGlas® has been used in combination with different types of barrier membranes 
in guided tissue periodontal regeneration as reported by (Mengel et al., 2003, 
Wadhawan et al., 2012). The clinical outcomes of these studies have reported 
significant improvement in periodontal parameters.  
 
Figure ‎1.10 Demonstrating the GTR procedure with and without bone grafting (Sheikh 
et al., 2014). 
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1.2.4 Bioactive Glass PerioGlas® (Bioglass®45S5) as a Synthetic Bone 
Graft Substitute in Dentistry: 
 
Periodontal disease(s) can initiate irreversible damage to the underlying periodontal 
tissues as manifested by a loss of the attachment apparatus and alveolar bone 
resorption (Socransky and Haffajee, 1997). Bone loss is regarded as a serious 
clinical problem in dentistry (periodontology), and the repair of damaged osseous 
tissues initiated by periodontal disease via the use of bioactive glass material as an 
alternative synthetic bone graft substance was a significant shift in perspective 
towards developing novel  products for dental use (AboElsaad et al., 2009). 
Historically, bioactive glasses have been used for the treatment of human 
conductive deafness, resorption of the alveolar ridge and to restore bone loss in 





 has been previously used in the surgical treatment of 
periodontal bony defects for the purpose of bone regeneration due to its ability to 
dissolve in physiological body solutions and releasing ions such as Na+, Ca2+, PO4
3- 
forming an apatite layer on the glass surface. The particles of this material when 
used in dentistry have the ability to form a cohesive cluster upon mixing with blood, 
with easy manipulation and packing into the surgical extracted sockets or 
periodontal defects (Schepers et al., 1998). This material is haemostatic and upon 
contact with body fluid, it can bond physio-chemically with the living bone and 
fibrous connective tissue without an intervening interfacial encapsulation (Wilson 
and Low, 1992). The outcome of the biological activity is the formation of a 
biological apatite identical to that of the mineral phase existing in natural bone, 
which in turn enhances bone damage repair and regeneration. However, the main 
rationale for periodontal therapy was to construct a healthy periodontium including 
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architecture, function and mechanical properties in order to restore both the lost 
periodontal and osseous tissues. 
PerioGlas® is a particulate form of bioactive glass (Bioglass®45S5), which has been 
used in dental applications since 1990 as a synthetic bone graft substitute (Chacko 
et al., 2014). PerioGlas® was approved by the US Food and Drug Administration 
(FDA) in 1984 for clinical applications of osteostimulation (Ali et al., 2014). Thermal 
incorporation of inorganic components of PerioGlas® such as calcium and 
phosphorous create a sodium silicate network which can be employed specifically 
for both absorbability and osteoconductivity. 
PerioGlas® has also been identified as a biocompatible and non-cytotoxic material 
(Wilson et al., 1981). Biocompatibility can be defined as "one that allows close 
contact of living cells at its surface, which does not contain leachables which 
produce inflammation and which does not prevent growth and division of cells in 
culture” (Shimizu et al., 1997). Furthermore, it has been stated that Bioactive 
glasses (PerioGlas®) may act primarily as an osteointegrative and osteoconductive 
material when exposed to body fluid (Wilson and Low, 1992). In comparison with 
the other synthetic materials such as hydroxyapatite ceramics, PerioGlas® develops 
a chemical interfacial bond with both hard and soft tissues through the development 
of the apatite gel layer on the surface of the glass. This in turn enhances the 
attraction and concentration of osteoblast cells, thus stimulating new bone 
deposition and osteoid mineralization (Hench and Ethridge, 1982, Wilson and 
Nolletti, 1990, Pazzaglia et al., 1989). 
The first animal studies on bioactive glass in the treatment of infra-bony defects as a 
bone filling material was undertaken by Wilson in 1987 (Wilson et al., 1987). It has 
been determined that the granules of bioactive glass act simultaneously as a bone 
filler in the periodontal defects enhancing bone proliferation within the defect.  
Page | 43  
 
A case study of two-walled defects was performed in the Patas monkey model to 
compare clinical and histological findings from the following materials and 
procedures: PerioGlas®, dense hydroxyapatite, tricalcium phosphate and an open 
surgical debridement technique to study their therapeutic effects on the host tissue 
response. Subsequently a significant reduction of the junctional epithelium migration 
was observed in the surgical sites grafted with PerioGlas®, where the migration 
stopped at the level of the material and bone was formed around the particles within 
four months. In contrast to the other implanted materials such as hydroxyapatite 
which exhibited much more junctional epithelium migration (Fetner et al., 1994). 
This report also showed the ease in handling and manipulation of the bioactive 
glass material compared to the other graft materials. 
A subsequent animal study was performed to evaluate the effect of Bioglass
®
45S5 
as a bone tissue substitute on the distal femur in the rabbit model (Chou et al., 
1998). This study demonstrated a positive response of Bioglass
®
45S5 to stimulate 
new bone growth. 
In a clinical study undertaken by Satyanarayana (Satyanarayana et al., 2012), the 
efficiency of PerioGlas® was evaluated in the treatment of intra-bony defects with 
localized aggressive periodontitis. Twelve patients with age ranges between 18 and 
25 years old have been treated with and without PerioGlas®. Through clinical and 
radiological investigations, the outcome was improved significantly with PerioGlas® 
test group than in the control group. This significant improvement was recorded by 
gaining clinical attachment level and reducing probing depth (P= 0.001). 
The evaluation of Bioglass
®
45S5 (PerioGlas®) as a therapeutic treatment of 
periodontal bony defects was reported by Sohrabi (Sohrabi et al., 2012). A meta-
analysis study of the data from clinical studies was used as shown in Table 1.6. This 
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meta-analysis study concluded that PerioGlas® was an efficient treatment for infra 
bony defects both in probing depth and clinical attachment level over both the 
control treatment and open flap debridement groups.        
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The biomedical device PerioGlas® (Block Drug Co., NJ, USA) is composed of a 
calcium phosphosilicate bioactive glass having a range of particle size from 90 to 
710 µm in diameter, as identified by optical microscopy (Dumitrescu, 2011). 
Furthermore, there are spaces between the large particles which play a role in 
accelerating the rate of osseo-integration and hard tissue ingrowth (Jones, 2015). 
However, the smaller particle size(s) of the bioactive glass may provide larger 
surface areas of glass with more sites for osteoblast adhesion, aggregation and new 
bone deposition. 
When PerioGlas® was implanted in vivo, an immediate exchange of ions occurs 
between the implanted glass and the surrounding environment. This results in 
releasing ions such as Ca2+ and PO4
3- which are then precipitated into the bone-like 
apatite on the glass surface forming an adherent-interface with biological tissues. 
This promotes the adhesion of osteoblast cells, which then enhances new bone 
growth. However, the release of cations, such as Na+ and Ca2+ generates a rapid 
pH rise, which is suspected to be too high in the extracellular environment 
particularly within the confines of the periodontal pocket, which is not considered in 
the previous studies. It should also be noted that this higher pH has two deleterious 
biological effects: (i) the alkaline pH inhibited osteoblast activity (specifically the 
alkaline phosphatase [ALP] activity), osteogenic differentiation and proliferation of 
the local biological environment as reported by Monfoulet et al. (Monfoulet et al., 
2014). This is an interesting bone tissue-engineering study investigating the 
drawbacks of Bioglass
®
45S5 and demonstrated the negative influence of a higher 
pH in the local biological environment on osteogenic proliferation; (ii) the higher pH 
can actually provide an optimal environment for the growth of one of the most 
virulent periodontopathic bacteria associated with the development of periodontitis, 
e.g. P. gingivalis. This bacteria has a huge battery of virulence factors for the 
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progression of periodontal diseases (Haffajee and Socransky, 1994). It has also 
been reported that “the optimum pH of activity in P. gingivalis was 8.3” (Takahashi 
and Schachtele, 1990). Therefore, the high pH generated by the silicate bioactive 
glasses dissolution in body fluid may result in an increased growth of P. gingivalis 
which may be detrimental for the initial wound healing stage within the bony defect.  
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1.3 Silicate Glass: 
 
1.3.1 Glass Definition: 
 
The glass can be defined as "A non-crystalline solid exhibiting the phenomenon of a 
glass transition" (Zarzycki, 1991). The identical physical state is known as the 
vitreous state. According to McMillan (1979), a glass may also be defined as "an 
inorganic product of fusion that has been cooled into a rigid condition without 
crystallization". 
Paul (1989) remarked that there was no significant difference between a glass and 
the equivalent liquid in terms of the irregular atomic arrangement of the glass; which 
was opposite to the regular atomic structure of a crystalline material (Paul, 1989). 
However, it should be noted that the glassy state has a short-range order between 
the atoms and lacks any long-range order. Accordingly, the X-ray diffraction pattern 
of glass should exhibit only diffuse haloes in contrast to the sharp peaks or lines 
obtained from a crystalline substance (McMillan, 1979). Glass can be manufactured 
by two main methods: the first is called the melt-derived route. This process 
requires less time and expenditure in order to prepare the glass which should be 
cooled rapidly in this process in order to avoid crystallisation, although it should be 
noted that this method necessitates the use of higher temperatures to melt the glass 
(1350°C – 1450°C). Glass crystallisation is prevented by cooling the glass as 
quickly as possible in order to restrict the opportunity of the atomic symmetrical 
long-range rearrangement to occur that exists within the crystalline lattice. Turnbull 
has advocated the rapid quenching method to prevent glass crystallisation 
(Turnbull, 1969). The second process known as the sol-gel method can produce 
bioactive glass at a lower temperature (600°C - 700°C) via the hydrolysis and 
condensation of tetraethylorthosilicate (TEOS) (Li et al., 1991). 
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The first silicate bioactive glass (Bioglass®45S5) was invented and developed by 
Professor Larry Hench and co-workers at the University of Florida in 1969. The 
original Bioglass® 45S5 composition was: 46.1% SiO2, 24.4% Na2O, 26.9% CaO 
and 2.6% P2O5 (mol%) (Hench et al., 1971). The bioactivity of bioactive glass was 
relevant to the formation of a surface layer of hydroxycarbonate apatite like deposit 
on the surface of the glass which resulted in the development of an adherent 
interface with the living bone tissues (Elgayar et al., 2005). Currently, bioactive 
glass 45S5 is available commercially in a range of clinical use such as NovaBone® 
for orthopaedic application, PerioGlas® for periodontal regeneration and anti-
hypersensitivity toothpastes NovaMin™ as well as for the remineralisation of teeth. 
However, more recently attention has focussed on developing new versions of 
bioactive glass compositions with improved physical and chemical properties for 
different dental and medical applications.  
 
1.3.2 Structure of Bioactive Silicate Glass: 
 
Glass structure can be described as the geometrical arrangement of the glass 
constituents, connecting with each other in a network. This arrangement is irregular 
and random, unlike the uniform organization of crystalline lattice. Physical and 
mechanical properties of the glass are determined significantly by its structure; 
therefore, a fundamental understanding of glass structure is essential in order to 
optimize the design of glass compositions for new technological applications as 
described by Tilocca (Tilocca, 2009). 
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1.3.3 Zachariazen’s‎Model‎of‎the‎Silicate Glass Oxides: 
 
The silica network in the vitreous state is composed of oxygen tetrahedra which 
encircle the silicon atoms (Figure 1.11). The oxygen tetrahedra share corners with 
each other in such a pattern that an oxygen atom is connected to two silicon atoms 
through partially covalent bonds (Zachariasen, 1932). Similarity in the principal 
structure of a polyhedral network between the glassy state and the crystalline 












Figure ‎1.11 The structure of SiO4 tetrahedra (Pudidotdk, 2009). 
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Both random atomic distribution in the glass network and the absence of molecular 
periodicity and symmetry (Figure 1.12), differentiates the glass structure from the 
crystalline structure and provides its amorphous XRD halo. However, the structural 
difference between the glass and the equivalent crystal is attributed to the variation 
in the bond angles and distances between the neighbouring tetrahedra.  
 
Figure ‎1.12 Molecular difference between: (A)-glass structure and (B)- crystalline 
(Zarzycki, 1991). 
 
Additionally, Zachariazen hypothesized that “the Si-O-Si bridge rupture mechanism 
leads to a loosened network structure with two types of oxygens: an oxygen bonded 
to two Si is called a bridging oxygen and an oxygen bonded to one Si is called a 
non-bridging oxygen” (Zarzycki, 1991). Accordingly, Zachariazen classified the 
oxides into three different categories as the following: 
1) Network formers: these oxides are considered as the essential components of 
glass structure, they are able on their own to form a glass upon rapid cooling. For 
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(P2O5). The most important glass former is the SiO4 tetrahedron where the silicon 
atom is bonded with an oxygen atom via the bridging oxygens.  
2) Network modifiers: these cations have the ability to disrupt Si-O-Si bonds and 
weaken the glass framework by forming non-bridging oxygens with highly ionic-
bonds between the non-bridging oxygen and these cations. Sodium oxide and 
calcium oxide are good examples of network modifiers. One non-bridging oxygen is 
formed by incorporating a monovalent cation (Na+) into the glass structure; whereas 
two non-bridging oxygens are created with a divalent cation (Ca2+) as shown in 
Figure 1.13. 
 
Figure ‎1.13 Network modifiers in the glass structure (Wallace et al., 1999). 
 
 
3) Intermediate oxides: these oxides are not usually able to form a glass on their 
own, but they can take part in the establishment of the glass network. Aluminium 
oxide is a typical example of an intermediate oxide. 
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Figure ‎1.14 Schematic diagram of the Hench mechanism for bioactive silicate glasses 
degradation (Mneimne, 2014).   
 
 
The mechanism of bioactive glasses degradation was initially proposed by Larry 
Hench (Hench, 1991) as shown in Figure 1.14. This glass degradation starts with 
the process of ion exchange, which includes the exchange of sodium ions from the 
glass with hydrated protons from the interstitial fluid resulting in a lack of protons 
from the surrounding body fluids with a simultaneous increase in the concentration 
of hydroxyl ions, and a subsequent local pH rise. Thereafter, the Si-O-Si bonds in 
 
1. Na+ ion exchanged for H+ / 
H3O
+ at the glass surface.   
 
2. Alkaline hydrolysis of Si-O-Si  
3. Formation of a SiO2 rich    
layer (silica gel) layer. 
4. Migration of Ca & P to the     
glass surface.  
5. Crystallization of CaO-P2O5 
film. 
6. Integration with collagen 
fibrils generated from 
human cells.  
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the glass network would be disrupted by the hydroxyl ions and alkaline hydrolysis, 
forming the Si-OH silanol group at the glass-solution interface. Due to the silanol 
concentration, a silica rich layer (known as a silica gel) is formed due to  
condensation repolymerisation of the silanol groups. Afterward, the migration of 
calcium and phosphate ions to the glass surface occurs producing an amorphous 
calcium phosphate rich film on the glass surface. Crystallization of the amorphous 
calcium phosphate rich layer occurs gradually due to further incorporation of ions 
from the solution such as hydroxyl and carbonate (Hill, 1996), which creates a 
mixed hydroxy-carbonate apatite layer (HCA). Osteoblasts attach to the apatite 
formed and produce Type I collagen on which further apatite forms resulting in new 
bone formation. 
However, Hench’s mechanism ignored the release of other network modifiers during 
the ion exchange step, such as calcium cations, which are likely to generate a high 
pH in the surrounding solution, leading to the suppression of the ion exchange 
process of the glass dissolution. This leads to a potential retardation of the apatite 
formation as demonstrated by Bingel et al. (Bingel et al., 2015), who stated that an 
alkaline buffer solution at pH 9 inhibited the apatite formation, whereas an acidic pH 
of 5 resulted in significantly faster apatite formation.  
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1.3.5 Theoretical Network Connectivity (NC) and Silicate Glass 
Bioactivity: 
 
According to the theory by Hill (Hill, 1996), network connectivity can be defined as 
“the average number of bridging oxygens per network forming element”. The value 
of network connectivity can be regarded as a good indicator to predict the glass 
bioactivity (defined as the speed at which apatite forms). It can also predict the 
glass dissolution behaviour and the susceptibility to glass-in-glass phase separation 
(Hill, 1996, Elgayar et al., 2005). The network connectivity is related to the average 
silicon Q distribution. The Q structure is defined as the number of bridging oxygens 
atoms connected to a silicon atom. The structure of the silicate glass is governed 
significantly by the proportion of bridging oxygens as shown in Figure 1.15. A 
silicate glass with four bridging oxygens/silicon has a Q4 structure and this would 
correspond to a network connectivity of 4, and a glass with two bridging 
oxygens/silicon would consist entirely of Q2 species. This would have a network 
connectivity of two. As a consequence, it is inevitable to conclude that there was a 
strong relationship between the network connectivity and the Q distribution model of 
the glass, this relationship may be categorized in the following manner: 
 In a pure silica glass where the network connectivity of 4 correlated with 
the Q4 species; 
 A network connectivity of three is correlated with Q3 glass structure such as 
three dimensional glass network; 
 A network connectivity of two is correlated with Q2 distribution which 
contains linear or two dimensional silicate chains; 
 A network connectivity of < two corresponds to Q structure < 2 as present 
in the case of an invert glasses.  




Figure ‎1.15 Schematic of the different Q structures that can describe Si network 
connectivity in silicate glasses. OB represents a network-forming bridging oxygen 
bond (Si–O–Si) (Martin et al., 2012). 
 
The network connectivity (NC) for the present study was calculated using the 
modified NC equation developed by Hill and Brauer (Hill and Brauer, 2011). It 
should be taken into account that the phosphate is present as negatively charged 
orthophosphate species (PO4
3-) where MI2O and M
IIO are the mono and divalent 
modifier oxides in the bioactive glass as in equation 1.1 below: 
                  NC =
4[SiO₂]−2[Mᶦ₂O+MᶦᶦO]+6[P₂O₅]
[SiO₂]
            (eq. 1.1) 
In order to satisfy the above model and achieve a bioactivity in the designed glass 
compositions, a glass network connectivity of two is usually preferred for optimal 
glass bioactivity as recommended by Hill (Hill, 1996) where the glass structure 
would have a linear or two dimensional chains of infinite molar mass. Glasses with a 
network connectivity higher than two, tend to be cross-linked or three dimensional 
structures; whereas below a network connectivity of two the glasses are very prone 
to an amorphous phase separation and crystallisation. These are referred to as 
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invert glasses, where the glass modifiers are present at higher molar concentrations 
than the network formers in the silicate network. 
 
1.3.6 Assessment of Silicate Glass Bioactivity: 
 
Hench (1980) used Tris buffer solution to test the surface bioactivity of the bioactive 
glass and reported that the bioactive glass had the ability to produce a silica gel film 
and calcium phosphate layer on its surface upon glass immersion in Tris buffer 
solution at pH 7.4 (Li et al., 1991). 
In order to investigate the bioactivity of the bioactive glass, Kokubo developed a 
highly supersaturated solution, known as simulated body fluid (SBF), which 
contained electrolytes in concentrations nearly identical to those ions present in 
human blood plasma (Kokubo and Takadama, 2006). SBF with its definitive recipe 
was approved in 2003 by the Technical Committee ISO of International 
Organisation for Standardisation as a recommended solution for the purpose of 
assessing and predicting bioactivity for in vitro studies measurement as well as for 
in vivo systems. 
The ISO standard test has been largely accepted by the scientific community and 
particularly those studying bioactive glasses, as a good indicator for evaluating the 
glass bioactivity (e.g., apatite formation). In the ISO test, a typical fixed surface area 
per solution volume ratio is usually used. It is however difficult to apply the ISO test 
for the glass powders that possess irregular particle shapes (Maçon et al., 2015), 
while it was considered reliable for testing the bioactivity of solid glasses with 
uniform geometric shapes only. This can include discs/monolithic and/or tiles 
shaped samples.  
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It is acknowledged that the formation of in vivo bone-like hydroxyapatite (HAP) is a 
fundamental requirement for a bioactive material to be able to bond with the host 
living tissue, when implanted in the human body. Similarly, this apatite formation 
can be reproduced in an in vitro environment when the material is immersed in the 
simulated body fluid (SBF) having ion concentrations consistent with concentrations 
found in human blood plasma. 
It is worth mentioning however that human blood serum is normally in equilibrium at 
CO2 partial pressure of 0.05 atm (5%) which is known to play a key role in buffering 
the blood serum pH. This condition however cannot be achieved in an in vitro 
serum-like solution (SBF) as proposed by Kokubo, since the controllability of 
carbonate content at such pressure can be problematic, and this may significantly 
alter the pH solution (Bohner and Lemaitre, 2009). Using the thermochemical 
calculations, Bohner and Lemaitre (Bohner and Lemaitre, 2009) reported that 
simulated body fluid (SBF) was a supersaturated solution with regards to apatite 
nucleation. This means that the SBF was initially a metastable solution and 
becomes thermodynamically stable thereafter once the apatite crystals are 
precipitated. However, the apatite crystallisation might simply be induced by the 
presence of external bodies such as the surface of a glass container or the edge of 
scratches. Thus, in order to ensure that apatite was formed from the inner surface of 
the glass during the time of immersion in the SBF solution, it was recommended to 
use plastic containers with smooth surfaces with the absence of any edge scratches 
(Bohner and Lemaitre, 2009). Evaluation of the glass bioactivity in two different 
physiological solutions; SBF and blood serum can, however, give false positive or 
false negative results, due to the fact that SBF composition was somewhat different 
from human blood serum, where proteins which are known to act as apatite 
nucleation inhibitors are absent (Bohner and Lemaitre, 2009). In addition, other 
materials for example, calcium sulphate hemihydrates can easily form apatite-like 
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phase in SBF solution, although it may not be possible to exhibit the similar 
behaviour in vivo (Walsh et al., 2003). Similarly, bone substitute materials such as 
beta-tricalcium phosphate (-TCP) was considered insoluble (inert) in SBF, but it 
has the ability of forming apatite and producing bone bonding in in vivo studies 
(Bohner and Lemaitre, 2009). If the above mentioned facts are taken into 
consideration, it would appear reasonable to suggest that SBF must not be 
considered as the ideal test for investigation the glass bioactivity behaviour and 
should be used with care. 
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1.3.7 Essential Constituents of the Bioactive Silicate Glasses: 
1.3.7.1 The Role of the Phosphate Content on Silicate Glass Structure 
and Bioactivity: 
Although there have been published studies on the effect of the phosphate content 
on the bioactive glass structure, this area is somewhat controversial. The key point 
however, is to understand the phosphate structure and speciation in the glass. 
Previously, it was hypothesized that phosphorus was incorporated into the bioactive 
silicate glass structure as a pyrophosphate complex by forming Si-O-P bonds 
(Ahsan et al., 2005, Mysen et al., 1981). On the other hand, other studies have 
reported that the phosphorus resides in the glass network as an orthophosphate 
species (Lockyer et al., 1995, O’Donnell et al., 2008b, Elgayar et al., 2005). 
Therefore, in order to investigate the effect of phosphate on the structure of 
bioactive glasses, O’Donnell et al. (O’Donnell et al., 2008b) studied two series of 
silicate glasses containing varying phosphate contents (0―9.25 mol%). The first 
and second series were designed based on the hypothesis that the phosphate 
existed either as a pyrophosphate phase Q1 or an orthophosphate species Q0 
respectively. As a result, the first series was designed by adding phosphate to the 
glass composition and substituting it for silica, while keeping the ratio of sodium 
oxide to calcium oxide fixed. In contrast, the second series was designed by 
increasing the phosphate content and simultaneously adjusting the amount of alkali 
metals (CaO and Na2O) to ensure charge balance for the suspected 
orthophosphate phase. 
In the first series, termed the non-charge balanced phosphate series, the network 
connectivity of the glasses increased as the phosphate content increased 
(O’Donnell et al., 2008b). This could be attributed to the polymerisation of the glass 
network upon the addition of phosphate to the glass structure, forming a less 
degradable glass with a negative effect on the glass bioactivity.  
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However, in the charge balanced series (O’Donnell et al., 2008b) the silicon Q 
speciation and glass network connectivity did not exhibit any change due to the 
addition of adequate modifier (Ca2+ and Na+) to neutralize the extra negative charge 
of orthophosphate species. The presence of separate orthophosphate species in 
the 45S5 glass composition and the absence of Si-O-P bonds however, has been 
confirmed by Pedone et al. studies (Pedone et al., 2010). 
Edén (Edén, 2011) stated that the phosphate content in the bioactive glass may be 
considered as an overriding factor. Increasing the phosphate content enhances the 
glass bioactivity, assuming the phosphorus is incorporated into the glass network as 
predominantly an orthophosphate (PO4
3-) species and the network connectivity is 
less than 2.6. Moreover, according to Edén’s suggestion (Edén, 2011), the range of 
network connectivity for bioactivity was between 2.0 and 2.6. However, the 
favourable network connectivity for the optimal bioactivity should be close to 2.0 
based on Hill's suggestion (Hill and Brauer, 2011) and below 2.4 according to 
Philips’s percolation theory (Phillips and Thorpe, 1985, Thorpe, 1983).  
Significantly, the relationship between the glass bioactivity and the phosphate 
content has been evaluated and it has been suggested that the phosphate content 
was a more influential factor for glass bioactivity than the network connectivity. This 
approach has been investigated through an in vitro bioactivity study by (O’Donnell et 
al., 2009). Two series of soda-lime-phospho-silicate glasses (as discussed earlier) 
were immersed in simulated body fluid (SBF) at different time points up to 21 days. 
In both series, the treated samples in (SBF) were then characterised by Fourier 
Transform Infrared Spectroscopy (FTIR) and X-ray diffraction (XRD) in order to 
reveal the presence of crystalline apatite formation. 
Based on the FTIR spectra and the Bragg peaks of XRD, both series glasses with a 
higher phosphate content (> 3.0 mol%) clearly exhibited a faster apatite deposition 
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in SBF in contrast to the equivalent glasses with a low phosphate content (< 3.0 
mol%). Furthermore, (O’Donnell et al., 2009) investigated the differential impact 
between the glass containing higher phosphate (6.33 mol% phosphate) versus 
45S5 Bioglass® (2.6 mol% phosphate) under identical experimental circumstances 
upon immersion in SBF up to 24 hours. The FTIR spectra demonstrated that the 
glass with a higher phosphate content formed more crystalline apatite after 1 day in 
SBF than 45S5 Bioglass® which showed less intense phosphate bands for apatite in 
the FTIR spectra. This observation would suggest that the optimal bioactivity may 
be achieved by increasing the phosphate content. 
However, it must be considered that the higher phosphate content could have a 
negative impact on the glass bioactivity depending on the structural design of the 
glass as suggested by (Tilocca and Cormack, 2007). In other words, there are 
limitations to increasing the amount of phosphorus content in the silicate glass 
composition. For example, if the phosphate enters the glass network as a 
pyrophosphate species which subsequently increases the network connectivity. This 
could generate a less resorbable glass and inhibit the apatite precipitation upon the 
glass’s exposure to physiological solutions, thereby reduces the glass bioactivity. 
  
1.3.7.2  Strontium (Sr2+) and its role on the Silicate Glass Structure and 
Bioactivity: 
It has been previously stated that strontium-substituted bioactive glasses may be a 
promising candidate as a therapeutic treatment in bone substitution (Fredholm et 
al., 2012). Therefore, strontium (Sr2+) releasing biomaterials have received 
significant attention for their medical applications due to their potential effect to 
support bone regeneration. Several investigators have reported that Sr2+ was well 
documented to have a dual simultaneous activity through its action to enhance 
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osteoblasts (bone forming cells) differentiation and inhibiting osteoclasts (bone 
resorbing cells) (Bonnelye et al., 2008, Gentleman et al., 2010). Sr2+ was also 
reported to induce osteoblast proliferation and increase alkaline phosphatase 
activity (ALP) without any deleterious effect on bone mineralization as assessed by 
the mineral deposition rate and osteoid thickness in alveolar bone (Marie et al., 
2001). Furthermore, the available studies report that Sr2+ disrupts osteoclast activity 
by breaking down the actin-containing sealing zone and increasing osteoclast 
apoptosis (Zhang et al., 2014). 
Previous evidence has also demonstrated that the Sr2+ can act as an antimicrobial 
agent at the same concentration at which it up-regulated osteoblast activity. The 
reason behind this is due to its ability to retard bacterial growth colonization and 
proliferation throughout “impeding permeability of cytoplasmic membrane, cell wall 
synthesis, replication of bacterial chromosomes and cell metabolism” (Brauer et al., 
2012). In addition, strontium was reported to have a bactericidal action against P. 
gingivalis (Liu et al., 2016) and therefore may be used as a therapeutic agent. 
Strontium resembles calcium (Ca2+) in terms of its charge to size ratio, and thereby 
can readily be substituted with Ca2+ in the lattice of hydroxyapatite (O’Donnell et al., 
2008a). Strontium accelerates both the glass dissolution rate and the ion release 
since it expands the glass network leading to weakening of the surrounding silicate 
network (Fredholm et al., 2012).  
On the other hand, a rapid dissolution rate of bioactive glasses containing strontium 
and faster ion release generates a higher pH rise, which in turn may suppress the 
first step of Hench’s theory of ion exchange (Na+ ion exchanged for H+ / H3O
+ at the 
glass surface) of bioactive glass dissolution and may subsequently retard the 
apatite formation. In terms of the inhibition of apatite formation by a higher pH rise, 
this was in good agreement with Brauer’s experimental data (Bingel et al., 2015). 
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Therefore, to address the problem of a rapid pH rise and to decelerate a faster 
dissolution process of bioactive glass, coarse particle size (100-400 µm) and higher 
P2O5 content have been deployed with a synthetic bioactive silicate glass in the 
current project. 
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1.4 Phosphate Glass: 
 
1.4.1 Structure of Bioactive Phosphate Glass: 
 
Phosphate glasses can be defined as inorganic polymers. They have been in use 
over the last 50 years for a variety of different applications due to the 
biocompatibility between their chemistry and the inorganic matrix of natural bone 
material. The biocompatibility of the phosphate glasses is attributed to their high 
solubility and release of ions into the biological environment. They have been used 
as agricultural fertilisers (Lee et al., 2005) as well as medical devices to release 
therapeutic ions from their oxides into the cellular media to function cell response 
stimulation (Neel et al., 2009). However, phosphate glasses are very reactive, highly 
soluble glasses with no precipitate formed in solution and extremely hygroscopic. 
They are connected together by non-bridging oxygen and metal cations forming 
three dimensional structures. Phosphorus pentoxide (P2O5) is the basic network 
former of the geometrical structure of phosphate glasses. The tetrahedron of 
phosphate glass is classified into four types of Q-speciation (Q3, Q2, Q1 and Q0) 
based on the number of bridging oxygens sharing the corner of neighbouring 
phosphate tetrahedra as demonstrated in the diagram below (Figure 1.16): 
 
Figure ‎1.16 Phosphate tetrahedra structure existing in phosphate glasses (Brow, 
2000). 
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In a phosphate glass the Qn terminology describes the number of bridging oxygens 
attached to the phosphorus atom to tailor the phosphate tetrahedron. In Figure 1.16 
the phosphate atom associated with four oxygen atoms is indicated by “Q” and “n” 
represents the number of bridging oxygen in the tetrahedral linkage varying from 
zero to three. However, phosphate glasses can be classified according to their 
chemical structure into five categories (Carta et al., 2007) namely: 1) 
ultraphosphates, 2) metaphosphates, 3) polyphosphates, 4) pyrophosphates and 5) 
orthophosphates as demonstrated in the Table 1.7. 
 
Table ‎1.7 Elucidating the Q structure of a phosphate glass with respect to its 
oxygen/phosphorus ratio (Carta et al., 2007). 
 
  
Q species of phosphate glasses versus oxygen/phosphorus 
ratio 
O/P Classification Qn geometry 
2.5-3 Ultraphosphate Q2+Q3 
3 Metaphosphate Q2 
>3 Polyphosphate Q2+Q1 
3.5 Pyrophosphate Q1 
4 Orthophosphate Q0 
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Similar to the silicate glass, the incorporation of modifier oxides into the phosphate 
network results in depolymerisation of the network via increasing the number of 
non-bridging oxygen bonds at the expense of reducing the number of bridging 
oxygen bonds. Thereby, negative charged non-bridging oxygens would be 
constituted which are neutralised by the positive charged metal cations. Typically, 
phosphate glasses require very low temperatures to be prepared and processed, 
thereby facilitating their incorporation with proteins, antibiotics and cancer therapies 
for use in medical treatment. 
Some studies (Bitar et al., 2004, Bitar et al., 2005, Salih et al., 2007, Lakhkar et al., 
2012) have investigated the chemistry of phosphate glass and developed several 
formulations with different modifiers in order to create an improved phosphate 
biomaterial potential for both soft and hard tissue regeneration. The incorporation of 
ions such as strontium into the system of phosphate glasses has been previously 
reported (Yang et al., 2010, Lakhkar et al., 2011) to up-regulate osteoblasts and 
down-regulate osteoclasts thereby providing a scaffold upon which new bone 
growth can occur.  
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1.4.2 Dissolution Mechanism of Phosphate Glass in Aqueous Medium: 
 
As with Hench’s mechanism of the silicate glass dissolution which is outlined in 
(section 1.3.4), Gao et al. (Gao et al., 2004) proposed the mechanism of phosphate 
glass dissolution by two interdependent steps as in Figure 1.17 below: 
(1) Step of ion exchange of Na+ cations with proton H+ or H3O
+ 
 
(2) Step of hydrolysis of P―O―P bond 
 
Figure ‎1.17 Mechanism of phosphate glass dissolution as proposed by Gao et al. 
(Gao et al., 2004). 
 
 
(1) Hydration process: the ion exchange reaction which involves the 
replacement of sodium ions from the phosphate glass with hydrated protons 
from the solution in order to perform Na–H ion exchange reaction, 
generating a hydrated layer on the glass surface. 
(2) Network cleavage: resorption of the hydrated layer, causing hydrolysis of 
P―O―P bonds by the attack of protons ions, resulting in the dissociation of 
the phosphate glass network and release different chains of polymerization 
of phosphate glass into the solution. 
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Based on Bunker et al. (Bunker et al., 1984), the kinetics of phosphate glass 
dissolution is determined by the Na–H ion exchange reaction in which the 
phosphate glass dissolves uniformly, where the composition of dissolution products 
in solution is identical with the bulk glass. Conversely, Liu et al. (Liu et al., 1996) 
suggested that the phosphate glass dissolution is dominated by disruption of 
phosphate glass network, whereas the role of Na–H ion exchange process is limited 
to hydrate the glass surface and establish the process of phosphate network 
breakage.  
Finally and to conclude, the limitations of silicate PerioGlas® are high pH, low 
phosphate content and free content of strontium. Stimulation of periodontal tissue 
regeneration and osteogenesis can be achieved by pH regulation, higher phosphate 
incorporation and strontium ions release. Therefore, to address these drawbacks, a 
novel silicate/phosphate glass mixture containing strontium with different fractions of 
particle size(s) will be created and investigated in this study. ALP will also be 
included due to its ability to hydrolyse the bonds of phosphate glass in glass mixture 
and deliver the orthophosphate ions for new bone formation. 
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1.5 Aim and Objectives of the Study: 
 
Aim: 
The main purpose of this project was to design novel degradable bioactive 
Silicate/Phosphate glass mixtures containing strontium for the therapeutic treatment 
of periodontal disease to be capable of: (i) the inhibition of the high alkaline bacterial 
growth of virulent P.gingivalis and (ii) the stimulation new bone mineralisation. 
Objectives: 
 To synthesize and characterize the new developed glasses using X-ray 
Diffraction (XRD), Differential scanning calorimetry (DSC), Fourier transform 
infrared spectroscopy (FTIR) and NMR spectroscopy. 
 To modulate and regulate the high alkaline pH generated by bioactive 
silicate glass dissolution in body fluids through the mixing of the silicate 
glass with a phosphate glass.  
 To investigate the ability of the novel synthetic glass mixtures to dissolve 
and form apatite upon immersion in both Tris-buffer (TB) and simulated body 
fluid (SBF) depending on the glass particle size.  
 To optimize a final novel bioactive glass composition which can be used as a 
promising bone graft material for therapeutic periodontal application. 
 
  
Page | 72  
 
2 Materials and Methods: 
 
2.1 Silicate Glass Design and Synthesis: 
 
The novel design strategy based on bioactive silicate glass 45S5 was to increase 
the phosphorus pentoxide (P2O5) content varying from 2.6 mol% in 45S5 to 5.61 
mol% in G10 (Table 2.1). it has been previously reported in published studies 
(Edén, 2011, O’Donnell et al., 2008b, O’Donnell et al., 2008c, O’Donnell et al., 
2009, Mneimne et al., 2011) that the higher phosphate content has an influence on 
enhancing the silicate glass bioactivity and accelerating apatite formation. 
Therefore, this phosphosilicate series was designed by increasing the phosphate 
content and simultaneously adjusting the amount of calcium oxide (CaO) to ensure 
charge balance for the suspected negatively charged orthophosphate species. This 
also helped to avoid polymerising the silicate glass network upon the phosphate 
addition, thus forming a degradable silicate glass with optimal bioactivity. Thus, the 
ratio of [CaO/(CaO+Na2O)] increased with an increased phosphate content. 
Although in the second series of O’Donnell et al. study (O’Donnell et al., 2008b), the 
negative charge of orthophosphate (PO4
3-) species has been neutralised by 
adjusting the amount of network modifiers sodium oxide and calcium oxide (CaO 
and Na2O) together to ensure charge neutrality. In the compositions developed 
here, only CaO was used to adjust the increasing phosphate content as higher 
sodium content is likely to cause spontaneous glass crystallisation. In addition, 10% 
of strontium oxide in molar percent was substituted for calcium oxide in the 
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 Table ‎2.1 Silicate glass composition in Mol% with a fixed NC of 2.1 of the glass 
series. 
 
A 200 g batch of analytical grade glass components, Silicon dioxide (Prince 
Minerals Ltd., Stoke-on-Trent, UK), Sodium Carbonate, Calcium Carbonate, 
Phosphorus Pentoxide and Strontium Carbonate (all from Sigma-Aldrich, 
Gillingham, UK) were mixed and placed in a platinum-rhodium (80/20) crucible and 
melted for 1 hour at temperature (1390°C - 1400°C) in an electric furnace (EHF 
17/3, Lenton, Hope Valley, UK). Subsequently, the glass melt was rapidly quenched 
in deionised water to prevent crystallisation. Glass frit was dried at 80 °C overnight 
in an electric dryer (Harvard LTE, UK). After drying, 100 g of glass frit was ground 
using a vibratory mill (Gyro mill, Glen Creston, London, UK) for 15 seconds to form 
glass powders, which were then sieved for 30 minutes by using mesh analytical 
sieves (Endecotts Ltd., London, UK), to obtain three fractions of glass particle sizes 
(fine < 38 μm, medium 38-100 μm and course 100-400 μm). Ultimately, all the glass 
powders were stored in dry plastic bags and saved in a dry desiccator for further 
use. 
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2.2 Phosphate Glass Design and Synthesis: 
 
Three phosphate glasses P1, P2 and P3 were prepared by using NH4H2PO4, 
SrCO3, K2CO3 and CaCO3 as starting materials. The investigated compositions of 
phosphate glasses are listed in Table 2.2. The precursors were weighed and placed 
in Platinum/Rhodium crucible with glass batch of 50 gram. Then, the crucible was 
placed in an electric furnace (EHF 17/3, Lenton, Hope Valley, UK) in order to melt 
the phosphate glass. The 22 hours temperature programme starting from 25°C 
(room temperature) and ending at 1150 °C, was used to slowly eliminate the gases 
produced by the decomposition of the batch materials such as H2O, NH3, and CO2, 
in addition to reduced evaporation of P2O5. 
 
Table ‎2.2 Phosphate glasses (P-glass) compositions in Mol% 
 
 
The procedure of making phosphate glass is described in Figure 2.1. Following 
placement the crucible with its content of phosphate glass composition in the 
furnace at approximately 25°C, the temperature was set up to be ramped to 100°C 
with heating rate [@5°C/min] and stayed for 1 hour. Then the temperature was 
ramped to 150°C [@5°C/min] and left for 30 min; afterwards the temperature was 
raised to 200°C [@2°C/min] and left for 2 hours. It was then further heated up to 
250°C [@5°C/min] and left for 1 hour. Then, the temperature was increased to 
300°C [@5°C/min] and kept for 2 hours. Thereafter it was raised to 600°C 
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[@2°C/min] and left for 5 hours. Then, it was further ramped to 900°C [@2°C/min] 
and kept for 2 hours. Finally, the temperature was ramped to 1150°C [@2°C/min] 
and left for one hour, and then the glass was poured. 
The molten phosphate glass was poured into a metal plate and covered by another 
metal plate. It was left for 10 minutes to be cool and then the glass was crushed and 
ground manually by the help of mortar and pestle. Then the glass frit was placed in 
sample plastic bags and labelled. Some samples of each composition were sent to 
the XRD lab to detect whether the glass is amorphous or crystalline, other samples 
were investigated in DSC for thermal analysis studies. By using a vibratory mill (Gy-
Ro mill, Glen Creston, London, UK), 50 g of phosphate glass frit was ground for 7 
minutes to form glass powders, which were then sieved for 30 minutes by using 
mesh analytical sieves (Endecotts, Ltd., London, UK) to obtain fine particle size < 
38 μm. Ultimately, all the glass powders were stored in dry plastic bags and saved 




Figure ‎2.1 Schematic diagram showing the range in temperature and ramping rate 
used to synthesize the experimental phosphate glasses. 
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2.3 Glass Characterisation (Solid and Solution State): 
 
2.3.1 Differential Scanning Calorimetry (DSC): 
 
A Stanton Redcroft DSC 1500 (Rheometric Scientific, Epsom, UK) was used for 
DSC measurements on all glass powders. DSC is a thermal analytical technique, 
which can be used to determine the glass transition temperature (Tg), crystallisation 
temperature peak (Tc) and melting temperature (Tm) as shown in Figure 2.3.   
A 50mg glass frit was placed in a Pt-Rh crucible and heated under Nitrogen 
(60ml/min-1) from room temperature (25°C) to (1000°C) at a heating rate of 
20°C/min using analytical grade alpha-alumina as a reference. The glass transition 
temperature (Tg) corresponding to the onset of the glass transition interval was 
extracted from the DSC plots with an accuracy of ± 5°C. 
 
Figure ‎2.2 A Stanton Redcroft DSC 1500. 
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Figure ‎2.3 Schematic model of DSC trace features demonstrating glass transition and 
crystallization temperatures.  
  
 
2.3.2 X-ray diffraction (XRD): 
 
In this project, an X’Pert Pro X-ray diffractometer (PANalytical, Eindhoven, The 
Netherlands) was employed to determine whether the prepared bioactive glasses 
were amorphous or crystalline. The amorphous phase of the glassy state displays 
only diffuse halos compared to the intense sharp peaks given by a crystal phase. 
XRD was also used to detect the crystalline phase of the apatite formed after 
immersing the bioactive glass in Tris and SBF solutions at specific time points for 
the purpose of investigating the glass bioactivity. A small amount of sample was 
used in this technique. A Bragg-Brentano flat plate geometry was used along with 
Cu Kα radiation (λ1=1.54059 Å and λ2=1.54442 Å). The patterns were collected from 
5 to 70° 2θ with a step interval of 0.0334° and a step time of 200.03 sec. The X-ray 
diffraction pattern was obtained by plotting 2-θ intensity as a function of 2-θ angle.  
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2.3.3 Fourier Transform Infrared Spectroscopy (FTIR): 
 
FTIR spectroscopy (Spectrum GX, Perkin-Elmer, Cambridge, UK) is a sensitive 
quantitative and qualitative technique, used to detect the amorphous nature of the 
untreated glass, the glass dissolution behaviour and possible formation of apatite 
crystals after studying the glass bioactivity in physiological solutions such as Tris 
buffer and simulated body fluid. FTIR (Figure 2.4) was employed to reveal the 
vibrations of the chemical atoms constructing the material. The infra-red spectrum is 
typically in the range between 4000-400 cm-1 since the infra-red frequencies within 
this range are identical to the essential vibrations of the active group of molecules 
(Doyle, 1992). The mode of FTIR used in the current project is called Attenuated 
Total Reflectance (ATR) and has been classified as a sampling technique which can 
be used together with the infrared spectroscopy to test a solid specimen. During the 
measurements the infrared beam initially passes through the ATR crystal and then 
reflects back from the internal surface that is in direct contact with the sample. This 
reflection produces evanescent waves which later continue to reach the sample with 
a typical penetration depth varies between 0.5-2 μm. The penetration depth value is 
highly dependent on the wavelength of light, the angle of incidence; as well as the 
incidence of refraction for the ATR crystal. Once the beam departed the crystal, it 
was collected by a detector and interpreted by Fourier transformation technique as 
interferogram signals. In this study, the data were collected from 500 to 1800 cm-1 
(wavenumbers). 
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Glass powder needed 
to be characterised 
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2.3.4 Particle Size Analyser: 
 
Particle size analysis was undertaken by using the Beckman Coulter LS 13 320 
Laser Diffraction (Figure 2.5). This particle size analyser was used to measure the 
size distribution of the glass particles. It works by measuring the intensity of the light 
scattering from the glass particles which are suspended in the distilled water 
through an exposure to the laser beam. The large angle of the scattered laser 
results in a small particle size and vice versa. The amount of sample required was 
related to the particle size range of the sample; the lower particle size the less 
sample required. The minimum amounts for selected ranges are: 0.5 g for <40 µm, 
1.5 g for 40-100 µm and 5 g for 100-500 µm.   
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2.3.5 Magic Angle Spinning-Nuclear Magnetic Resonance (MAS-NMR): 
  
Magic Angle Spinning-Nuclear Magnetic Resonance (MAS-NMR) is a powerful 
technique used to study the physical and chemical properties of atoms and 
molecules of materials by providing full details and information of their dynamics, 
chemical structure and reaction state. A wide range of solids and solutions samples 
can be studied by using this technique. In this project, the 31P MAS-NMR was 
carried out using the Bruker probe and 600MHz Bruker spectrometer with 
permanent magnetic field of 14.1 Tesla at the resonance frequency of 242.9 MHz. 
Two different spinning speeds were set up for the solid sample depending of the 
rotor used 22 kHz for 2.5 mm rotor and 12 kHz with 4 mm rotor. The solid sample 
was run for 32 minutes using a rotor 2.5 mm and 16 minutes in case of rotor 4 mm. 
The recycle delay of 60 s was used. The reference of the chemical shift was 85% 
H3PO4. The chemical species of 
31P nucleus and glass structure were interpreted by 
the chemical shift and the intensity of the peaks. Both untreated and treated glass 
samples were investigated in this technique.  
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2.3.6  31P Solution State NMR spectroscopy: 
  
The 31P solution NMR was run on a Bruker Avance III 400 MHz spectrometer. The 
frequency for 31P was 162.0 MHz. 32 scans were acquired with a spectral width of 
395.7 ppm (64102 Hz) were used prior to acquisition. The important NMR point 
being that ~10% Heavy Water D2O was added to them for the field/frequency lock. 
This analysis was performed by transferring 500 microliter of the aqueous samples 
required to be run into the NMR tubes (Wilmad® NMR tubes 5 mm diameter) 
together with 50 microliter of D2O using a Gilson pipette. The D2O was required for 
two purposes: (i) as a  reference to compensate for magnetic field fluctuations which 
are  significant for solution spectra where the line width is of the order of 1 Hz, and 
(ii) as the means of adjusting magnetic field homogeneity  
to obtain sharp lines. 
 
2.3.7 Inductively Coupled Plasma–Optical Emission Spectroscopy 
(ICP-OES): 
 
ICP-OES (Varian Vista-PRO, Varian Ltd., Oxford, UK) is a sensitive technique used 
to measure ions in the filtered solution such as Ca2+, Si4+, P5+, Na+, K+ and Sr2+ 
concentrations up to a very low concentration (as low as 0.1 ppm). The advantages 
of ICP-OES are related to the qualitative and quantitative measurement of the 
investigated samples. In addition, through ICP-OES many different elements can be 
measured at the same time to provide profile of ions released from the tested 
solution.  
In this study all samples were acidified by using 69% nitric acid (VWR International 
Ltd) before analysis in order to prevent precipitation of ions during solution analysis. 
In silicate glass, the dilution of the samples with deionised water was (1:4), whilst 
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the dilution in glass mixtures was (1:33.3). Different dilution was accounted to the 
difference in the ions concentration released from different original glasses.  
 
2.4 Bioactivity Test (Immersion Test): 
 
2.4.1 Tris Buffer Solution (TB): 
 
This solution is free of calcium and phosphate ions and it can be used to investigate 
the bioactivity of the glass to dissolve and form apatite. Tris buffer was prepared by 
adding 15.09 g of Tris (hydroxymethyl aminomethane) (Sigma-Aldrich, Gillingham, 
UK) into 800 ml of deionised water. Afterwards, 44.2 ml of 1M HCl (Sigma-Aldrich, 
Gillingham, UK) was slowly added to the solution under stirring, the resulting 
solution was then put in a plastic bottle and kept in a shaking incubator overnight at 
37°C. The next step involved the adjustment the pH of the solution by slowly adding 
1 M HCl using pH meter (Oakton Instruments, Nijkerk, the Netherlands). Once the 
pH value of the solution has reached 7.35, the solution was transferred into 2 litres 
flask and diluted by adding deionised water to fill up to a volume of 2 litres.  
 
2.4.2 Simulated Body Fluid (SBF): 
 
SBF is a highly supersaturated solution, which contains electrolytes in 
concentrations roughly similar to those ions existing in human blood plasma; 
therefore, it is useful to assess the bioactivity of the glass. SBF was prepared as 
described by Kokubo et al. (Kokubo et al., 1990) in two steps. In the first step, the 
following chemical reagents were added slowly and sequentially into 1500 ml of 
deionised water: 15.992g of NaCl, followed by 0.70g of NaHCO3, 0.448g of KCl, 
then 0.456g of K2HPO4.3H2O, 0.610g of MgCl2.6H2O, 70ml of 1.0M HCl, 0.736g of 
CaCl2.2H2O, 0.142g of Na2SO4 and finally 12.114g of Tris hydroxymethyl 
aminomethane (all Sigma-Aldrich, UK). The resulting solution was kept in two litres 
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polyethylene bottle in an incubator overnight at 37ºC. The second step was the pH 
adjustment to 7.35 at 37ºC by slowly adding 1 M HCl to the solution. The pH change 
was measured by using pH meter (Oakton Instruments), and then the solution was 
transferred into two litres of deionised water. The completed SBF solution was kept 
in an incubator at 37ºC prior to use for dissolution studies.  
2.4.3 ALP Enzyme Containing Tris Buffer Solution: 
 
This solution was made by adding 1.53 microliter of bovine ALP (Sigma-Aldrich) into 
100 ml Tris buffer solution. This addition was performed based on the calculated 
concentration of ALP enzyme in GCF of periodontal bony defects (Sanikop et al., 
2012). Then, the resulting solution was kept in an incubator shaker (KS 4000 ic 
Control, IKA, Germany) at temperature 37ºC and pH 7.35 to be used for immersion 
test.     
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2.5 The Procedure of Glass Dissolution: 
 
2.5.1 The Immersion Test of the ISO-Standard and Non-ISO-Standard 
Bioactivity Tests in Tris Buffer: 
 
In order to assess the glass bioactivity (the apatite formation rate), the ISO-
Standard and Non-ISO-Standard methods were used in the present study (Figure 
2.6). The ISO-Standard test was performed for a fixed surface area per solution 
volume ratio where 0.5 g of glass powder was immersed in 10ml Tris buffer solution, 
whereas the Non-ISO-Standard bioactivity test was used for a Non-Fixed ratio 
where 0.075 g of glass powder was immersed in 50ml Tris buffer. 
 
Figure ‎2.6 Schematic diagram illustrating the ISO-Standard and Non-ISO-Standard 
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2.5.2 The Immersion Test of the Influence of Bioactive Glass Particle 
Size on Glass Dissolution Rate, pH and apatite Formation in SBF: 
 
In this process, 0.075 g of glass powders were immersed in 50 ml of SBF using 
three fractions of glass particle size (<38 µm, 38-100 µm and 100-400 µm) (Figure 
2.7). 
 
Figure ‎2.7 Schematic diagram illustrating the immersion test of the influence of the 
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2.5.3 The Immersion Test of the Silicate/Phosphate Glass Mixtures 
Dissolution Process in Tris Buffer and ALP Enzyme Containing 
Tris Buffer Solution: 
 
In these experimental works, 0.15 g of the silicate/phosphate glass mixtures was 
immersed in 10 ml for both Tris Buffer and ALP Containing Tris Buffer Solution 
(Figure 2.8). 
 
Figure ‎2.8 Schematic diagram illustrating the immersion test of the Silicate/Phosphate 
glass mixtures in TB and ALP containing TB Solution. 
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2.6 General Immersion Protocol: 
 
Overall, after immersion the glass powders in all of the three processes mentioned 
above, the suspended solutions were placed in plastic containers and these 
containers were kept in a shaking incubator at 37ºC for a specific period based on 
the range of immersion time points of the experiment. At the end of each immersion 
time point, the samples were taken out from the incubator and the pH change was 
measured by a pH meter (Oakton Instruments, Nijkerk, Netherlands). Then, the 
suspended solution was filtered using filter paper (Fisher Scientific with a diameter 
of 150mm) and the collected solid powders were placed in Petri dishes and kept in 
drying cabinet at 37ºC overnight. While, the filtered solutions were kept in falcon 
tubes (Fisher Scientific) and stored in a fridge at 4ºC. The dried collected solid 
powders were characterised by using FTIR, XRD and 31P MAS-NMR techniques to 
investigate the apatite forming ability of the glass, whilst the filtered solutions were 
characterised by ICP-OES analysis to study the ion release trend. Two 
measurements were used for the individual glass compositions at each time point; 
the standard deviations were estimated to be ± 0.2 for the ions released and ± 0.1 
for the pH data.  
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Bioactive silicate glasses dissolve in body fluids releasing Ca2+, PO4
3- ions and form 
a hydroxycarbonate apatite-like layer. The 45S5 glass known as Bioglass® is sold 
under the trade names NovaBone and PerioGlas® and was used as a bone grafting 
material and for treating periodontal disease. 
Hench first developed Bioglass® in the late 1960s. He identified the mechanism of 
bioactive glasses degradation (Hench, 1991). Whilst this mechanism is widely 
accepted, it does not explain the high dependence of glass dissolution and 
bioactivity on the silica content and on the network connectivity of the glass 
(Elgayar, 2004). 
The first step in the mechanism involves the ion exchange of Ca2+ and Na+ ions for 
protons in the external medium. This ion exchange process results in an increase in 
the local pH. Brauer and co-workers have shown that glass dissolution is inhibited 
by pHs > 8 (Bingel et al., 2015). The pH rise that results from the initial dissolution 
of the bioactive silicate glasses can inhibit further dissolution and apatite-like phase 
formation. The high pH can result in cytotoxicity (Monfoulet et al., 2014), but may 
also favour hydroxyapatite formation since hydroxyl ions are needed for the 
formation of hydroxyapatite. In some cases the high pH along with the relatively 
high ion concentrations can be beneficial, since many of the bacteria involved in 
wound infections grow optimally under acidic conditions e.g. osteomyelitis (Alomar 
et al., 2008). This is particularly the case with osteomyelitis and the 53P4 glass 
composition, which is sold under the trade name BoneAlive®, which has a well-
documented clinical efficacy in treating osteomyelitis (Drago et al., 2014, Drago et 
al., 2015). Cariogenic bacteria involved in tooth decay also have optimum growth at 
acidic pHs. However, many of the bacteria involved in periodontal disease in 
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contrast have optimum growth at pHs > 8. For example P. gingivalis the organism 
widely regarded as playing a key orchestrating role in periodontitis (Haffajee and 
Socransky, 1994) has an optimum growth at a pH of about 8.3 (Takahashi and 
Schachtele, 1990). Whilst the high pH generated by bioactive silicate glasses may 
be attractive for many applications it could be detrimental for treating periodontal 
disease, particularly if pocket debridement/cleaning is incomplete leaving behind 
viable bacteria. Under these circumstances the high pH generated by a bioactive 
silicate glass could stimulate the bacteria involved in periodontal disease. The use 
of 45S5 in the form of PerioGlas® has received a mixed reception from clinicians 
either good (Lovelace et al., 1998) or bad (Singh et al.). The potential high pH 
generated by NovaBone (PerioGlas®) could also be detrimental, particularly where: 
i) there is a relatively low turnover of body fluids at the implant site 
ii) the defect size to be grafted is large 
iii) The glass particles are densely packed and the fluid flow through the 
construct is low.  
The bioactivity of bioactive glasses is often performed by following their dissolution 
and apatite-like phase forming ability in simulated body fluid that mimics the ionic 
concentration of ions found in body fluids (Kokubo and Takadama, 2006). However, 
the clinical relevance of this test has been questioned (Bohner and Lemaitre, 2009). 
This test specifies a glass surface to volume ratio. However, the clinical use of 
bioactive glass will not involve a fixed ratio of glass to body fluid and furthermore 
this body fluid will have a continuous turnover. However there is virtually no data on 
the turnover of fluids in different bone sites. 
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3.2 Silicate Glass Characterisation (Results and Discussion): 
 
3.2.1 X-ray Diffraction (XRD) Results: 
 
 
Figure ‎3.1 XRD patterns demonstrate that all the unreacted phosphosilicate glasses 
were amorphous. 
 
The XRD patterns in Figure 3.1 demonstrate that all glasses in this phosphosilicate 
series including 45S5 reveal broad halos localised around 32° 2-Theta, which is a 
characteristic feature of an amorphous structure. It is essential to evidence the 
amorphous state of these unreacted glasses before performing the bioactivity tests 
because the presence of crystalline species results in suppression of the ion 
exchange reaction of glass dissolution in physiological buffer solutions, 
subsequently inhibiting the apatite forming ability.  
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3.2.2 Fourier Transform Infrared Spectroscopy (FTIR) Results: 
 
Figure ‎3.2 FTIR spectra demonstrate that all unreacted glasses in phosphate series 
were amorphous. 
 
The FTIR spectra in Figure 3.2 reveal that all the glasses including the 45S5 are 
amorphous as indicated by the presence of: (i) only broad bands as expected for an 
amorphous solid as opposed to the sharp features that would indicate the presence 
of crystalline species; (ii) well-defined bands at 920 cm-1, which is assigned to non-
bridging oxygens (Si-O--M+, where M+ is an alkali metal modifier cation) and also (iii) 
vibrational stretches at 1030 cm-1 of Si-O-Si in the silicate glass network (Jones et 
al., 2001); (Brauer et al., 2010). The major difference in the spectra of the glasses is 
the vibrational P-O band at 580 cm-1 which is more pronounced with higher 
phosphate content and is particularly strong in G10 (the highest phosphate content). 
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has been observed previously by a number of authors (O’Donnell et al., 2008c, 
Mathew et al., 2013, Mneimne, 2014). 
 
3.2.3 Particle Size Analysis Results: 
 
 
Figure ‎3.3 The particle size analysis of all silicate bioactive glasses. 
 
The results of the particle size measurement (in micrometres; µm) of 45S5 and all 
the experimental glasses G2, G4, G5 and G10 are shown in Figure 3.3, expressed 
by d10, d50 and d90. The d10 gives the size for which 10% of the glass particles by 
volume within distribution are smaller than the given value. The d50 value 
represents 50% of the glass particles by volume are larger and 50% are smaller, 
d90 gives the value above, which 90% are coarser than the given value. 
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Table ‎3.1 The particle size distribution of 45S5 and experimental glasses. 
 
Furthermore, Table 3.1 demonstrates that d90 of all experimental glasses including 
45S5 have coarse particle size greater than 400 µm, whereas d10 and d50 of these 
glasses have particle size distribution within the range (100-400 µm), which has 
been used in this research to evaluate the apatite forming ability upon silicate glass 






    
Bioactive glasses 
 d10 d50 d90 
45S5  147.5 ± 5.9 
 
274.8 ± 8.2 
 
467.8 ± 1.9 
 
G2  138.1 ± 0.4 
 
259.1 ± 11.3 
 
464.9 ± 11.8 
 
G4  145.0 ± 0.0 266.6 ± 4.6 
 
475.7 ± 14.4 
 
G5  161.6 ± 5.8 
 
305.9 ± 14.8 
 
510.1 ± 4.8 
 
G10  125.3 ± 1.3 254.4 ± 11.3 449.9 ± 2.7 
Particle size (100-400 µm) 
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Figure ‎3.4 Graph demonstrating glass transition temperature (Tg) vs P2O5 content 
(mol%), where R² = 0.9661 and the equation for the trend line is y = 4.1x + 503.55. 
 
Figure 3.4 shows that there is a linear relationship between the glass transition 
temperature (Tg) and the phosphate content of the glass series. An increase in Tg 
can be observed with increased phosphate content and increased Ca2+ 
concentration in the glass series, this trend in Tg can be related to the increase in 
the divalent cation (Ca2+) concentration, which increases the ionic cross-linking 
between two Si-O- species (two non-bridging oxygens) in adjacent silicate chains of 
the silicate glass network. Therefore, the electrostatic forces between non-bridging 
oxygen atoms become considerably more intense, resulting in an increase in Tg. 
However, it has been observed in the O’Donnell et al. study (O’Donnell et al., 
2008c) that the Tg lowers with increasing phosphate content due to the silica 
content reduction in the bioactive glass compositions, upon phosphate addition with 
both calcium oxide and sodium oxide charge adjustment.  
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3.3 Bioactivity Dissolution Tests: 
 
3.3.1 The ISO-Standard and Non-ISO-Standard Bioactivity Test: 






Figure ‎3.5 The pH behaviour of three glass compositions on immersion in Tris buffer 
solution during the (a) ISO-Standard and (b) Non-ISO-Standard bioactivity tests. The 
time scale is in days for (a) and in hours for (b). Three compositions studied are 45S5, 
G2 with 10% of Sr substituting for Ca in 45S5 composition, G10 with additional higher 





























(a) ISO-Standard bioactivity test 
(b) Non-ISO-Standard bioactivity test 
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As a general trend, a high alkaline pH up to 9 is generated in buffers during the ISO-
Standard bioactivity test of the glass powder as indicated in (Figure 3.5 (a)). 
Whereas, the pH does not rise much compared to the initial value of 7.3 during the 
Non-ISO-Standard test as described in (Figure 3.5 (b)). The dramatic pH rise seen 
in the ISO-Standard bioactivity test is associated with an instant high release of 
calcium and sodium cations into a small volume of the buffer solution, which rapidly 
exceeds its buffering capacity. Therefore, the pH increases due to the higher glass 
concentration immersed in solution resulting from excessive amount of cations 
replacing the hydrated proton (H+) ion for ion exchange reaction in the solution, 
causing a pH rise.  
Moreover, the pH of G10 glass solution in the ISO Standard test (Figure 3.5 (a)) at 
different time points of the experiment is higher than for the solution containing 
45S5. Whilst, the higher phosphate containing bioactive glass exhibits reduced pH 
rise due to the increased release of phosphate ions from the glass into the solution 
as reported by O’Donnell et al. study (O’Donnell et al., 2009). Therefore, the 
increase in the pH of G10 glass in the ISO Standard test could be attributed to the 
particles size distribution. The d10, d50 and d90 values for G10 glass as given in 
Table 3.1 appear to be less than that of 45S5 and the other glasses. The G10 glass 
therefore has a smaller particle size and consequently a larger surface area which 
gives rise to a faster ion exchange and a higher dissolution rate. Thus, greater 
quantities of cations such as calcium and sodium are released from the surface of 
G10 glass into the solution through ion exchange process with the protons from the 
solution into the glass causing a reduction in the H+ concentration and a higher pH 
rise in solution.  
The experimental pH data of the whole glass series (45S5, G2 and G10) in the ISO 
Standard test are in good agreement with the previous findings reported by the 
Jones et al. study (Jones et al., 2001). Jones and co-workers suggested that the 
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higher glass amount in solution, the higher the pH rise. Therefore, the amount of the 
bioactive glasses influences significantly on the glass dissolution and pH profile. 
This phenomenon appears to be of some significance in periodontology, since the 
high concentration of Perioglas® in periodontal pocket causes high release of 
cations such as Na+ and Ca2+ into the extracellular environment. This in turn 
generates a pH rise which is suspected to be too high regarding the small volume of 
a periodontal pocket as discussed previously in section 1.2.4. 
On the other hand, the pH of the G10 glass solution in the Non-ISO-Standard test 
(Figure 3.5 (b)) is slightly lower than that of the 45S5 solution. To some extent, this 
pH behaviour could be reasonable since the pH reduction could be attributed to the 
high phosphate concentration in the composition of G10 glass as supported by 
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Figure ‎3.6 FTIR spectra of 45S5 glass (PS 100-400 µm) before and after immersion in 
Tris during the (a) ISO-Standard test and (b) Non-ISO-Standard test bioactivity test. 
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Figure ‎3.7 FTIR spectra of G2 glass (PS 100-400 µm) before and after immersion in 
Tris during the (a) ISO-Standard test and (b) Non-ISO-Standard test bioactivity test. 
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Figure ‎3.8 FTIR spectra of G10 glass (PS 100-400 µm) before and after immersion in 
Tris buffer during the (a) ISO-Standard test and (b) Non-ISO-Standard test bioactivity 
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The FTIR results of the compositions 45S5, G2 and G10 obtained via the ISO-
Standard method are presented in Figure 3.6 (a), Figure 3.7 (a) and Figure 3.8 (a) 
respectively. No apatite formation was present in 45S5 and G2 glasses over the 
entire time of experiment up to 14 days despite partial glass dissolution indicated by 
the partial disappearance of silicon-non-bridging oxygen bond (Si+-O-- alkali+) at 920 
cm-1 of unreacted glass. However, there was a small amount of apatite in G10 after 
14 days immersion in Tris buffer ISO-Standard. Apatite formation in G10 through 
the ISO-Standard test is favoured by the high phosphate content.  
The inhibition of apatite precipitation in the ISO-Standard test is, therefore likely to 
be associated with the following reasons: 
(i) The high pH rise, which could probably inhibit the glass dissolution by 
suppressing the ion exchange process. This process involves the exchange 
of sodium and calcium ions from the glass with hydrated protons from the 
solution. Therefore, the suppression of ion exchange causes retardation of 
apatite formation. 
(ii) The ratio of calcium to phosphate ions could probably increase because of 
the excessive amounts of bioactive glass which are immersed in solution. 
Consequently, calcium carbonate (calcite) may therefore be precipitated on 
the surface of the glass particles at the expense of hydroxyapatite formation.  
 
The FTIR spectra of selected glasses 45S5 and G2 that reacted in Tris buffer 
indicated that there was no apatite precipitation over the immersion periods of up to 
14 days through the ISO-Standard experiments. Whereas, the apatite formation was 
observed earlier at eight hours of immersion in the Non-ISO-Standard test. The 
FTIR results revealed that the developed glass G10 with high phosphate content 
reduced the rapid pH rise and accelerated apatite formation in Tris buffer. 
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The inhibition of apatite formation due to the high pH rise in the ISO-Standard test 
was largely in agreement with the findings of Bingel (Bingel et al., 2015), who 
indicated that the alkaline buffer solution at pH 9 inhibited the apatite formation. 
While, the inhibition of apatite formation due to the precipitation of calcium 
carbonate on the surface of the glass was consistent with the Jones et al. 
observations (Jones et al., 2001).  
However, the ISO-Standard method was employed to investigate the influence of 
pH on the glass degradation rate and apatite forming ability. This pH was suggested 
to be too high within the small volume of the periodontal bony defect. Therefore, this 
needed to be taken into consideration when the bioactive glass is being designed 
for future periodontal grafting materials. 
The FTIR spectra of the Non-ISO Standard samples are shown in Figure 3.6 (b), 
Figure 3.7 (b) and Figure 3.8 (b). As a general trend, the FTIR spectra in the Non-
ISO Standard test exhibited the prominent features of the glass dissolution in Tris 
buffer, which are indicated by the disappearance of silicon non-bridging oxygen at 
920 cm-1. As the immersion time progresses, the intensifying of the Si-O-Si 
vibrational peak at approximately 1020 cm-1 (stretch) appeared well-defined in the 
FTIR spectra, which represented the formation of silica gel layer. At longer 
immersion times, the well-developed split bands at about 560 cm-1 and 600 cm-1 
appeared; indicating the presence of crystalline apatite formation. The faster apatite 
formation was evident with G10 glass at approximately 4 hours (Figure 3.8 (b)) due 
to the significant effect of the higher phosphate content on the rate of apatite 
formation. It was reported that the high phosphate content enhanced the glass 
bioactivity and accelerated the apatite formation rate (O’Donnell et al., 2009, 
Mneimne et al., 2011).  
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3.4 The Influence of Bioactive Glass Particles Size on Glass 
Dissolution Rate, pH and apatite Formation: 
 
In order to investigate the influence of the bioactive glass particle size (PS) on the 
glass dissolution rate, pH behaviour and apatite forming ability, three fractions of 
particles size (<38 µm, 38-100 µm and 100-400 µm) have been used in this 
investigation. 
3.4.1 Particle Size Analysis Results: 
 
 
Figure ‎3.9 Graph showing particle size analysis for three fractions (<38 µm, 38-100 µm 
and 100-400 µm) of the selected silicate bioactive glasses 45S5 and G10. 
 
Figure 3.9 illustrates the particle sizes measurement (in micrometres; µm) of the 
45S5 and the G10. The particle size distribution is expressed by the d10, d50 and 
d90 values for three fractions of both glasses (<38 µm, 38-100 µm and 100-400 
µm). 
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Table ‎3.2 Particle size distribution of 45S5 and G10 glasses for three fractions (<38 
µm, 38-100 µm and 100-400 µm). 
 
Table 3.2 illustrates the particles size distribution of the 45S5 and G10 glasses, 
giving three fractions (small, medium and large) for each glass. As observed in 
Table 3.2, the d90 particle size was greater than the sieve size of each glass. 
Whereas 10% and 50% of these glasses have particle size distribution within the 
designed range. It should be noted that the particle size analysis software interprets 
the glass particles as spherical particles whereas angular particles with an 
equivalent spherical radius larger than the mesh size would pass through the mesh. 
Therefore, the particle size analyser may record higher values than the sieve size.    
  
    
Bioactive glasses 
d10 d50 d90 
45S5 <38 µm 3.8 ± 1.2 20.7 ± 0.0 41.6 ± 0.2 
45S5 38-100 µm 39.2 ± 0.4 78.7 ± 1.8 136.0 ± 5.0 
45S5 100-400 µm 147.5 ± 5.9 274.8 ± 8.2 467.8 ± 1.9 
G10 <38 µm 2.8 ± 0.1 21.7 ± 0.3 42.9 ± 0.3 
G10 38-100 µm 37.8 ± 1.3 72.5 ± 2.6 120.8 ± 5.7 
G10 100-400 µm 125.3 ± 1.3 254.4 ± 11.3 449.9 ± 2.7 
Particle size (µm) 
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Figure ‎3.10 FTIR spectra before and after immersion in SBF were plotted as a function 
of time for (a) 45S5 PS <38 µm, (b) G10 PS <38 µm, (c) 45S5 PS 38-100 µm, (d) G10 PS 
38-100 µm, (e) 45S5 PS 100-400 µm and (f) G10 PS 100-400 µm. 
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The significant relationship between the glass bioactivity (glass dissolution and 
apatite formation) and glass particles size in SBF can be observed in Figure 3.10. 
As a comparison between the FTIR spectra of 45S5 <38 µm and the FTIR spectra 
of 45S5 100-400 µm, the glass dissolution rate in SBF was faster with small 
particles (Figure 3.10 (a)) than the large particles (Figure 3.10 (e)). This difference 
was indicated by: (i) faster disappearance of a silicon non-bridging oxygen at 920 
cm-1 of unreacted glass over the entire time of the experiment (i.e. the glass 
dissolved completely) compared to the glass dissolution behaviour of the same 
glass. The disappearance of silicon non-bridging oxygen in (Figure 3.10 (e)) was 
slower and i.e. there were still unreacted glass particles. And (ii) the sharpening 
(stretch) of the Si-O-Si located at approximately 1020 cm-1 as a function of time 
(Figure 3.10 (a)) was clearly more pronounced than that in (Figure 3.10 (e)). 
Therefore, the small particle size accelerated the dissolution rate of the glass in 
solution. Similarly, the FTIR results of the G10 glass with a fine particle size <38 µm 
(Figure 3.10 (b)) revealed a rapid G10 glass dissolution in SBF compared to the 
G10 glass with a coarse particle size 100-400 µm (Figure 3.10 (f)). 
With respect to the effect of the glass particle size on the apatite formation, it can be 
observed that the coarse particle size of 45S5 100-400 µm accelerated the apatite 
formation. The apatite formed within the earliest time point of immersing 45S5 in 
SBF as demonstrated in (Figure 3.10 (e)). In contrast, the fine particle size <38 µm 
of 45S5 did not speed up the rate of apatite formation (Figures 3.10 (a)). The apatite 
precipitated after 18 hours of 45S5 treatment in SBF in spite of emerging single 
peak at 570 cm-1 during earliest immersion time point. This peak can be attributed to 
the P-O vibration bond indicating the emergence of apatite precursors; i.e. the 
development of amorphous calcium phosphate layer (Brauer et al., 2008). However, 
with longer immersion times, this single peak then splits approximately at 18 hours 
(Figure 3.10 (a)) into two distinct bands at 560 and 600 cm-1 forming the apatite 
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crystal phase. Similar comparisons were observed between the FTIR spectra of the 
G10 fine particle size <38 µm and the G10 coarse particle size 100-400 µm as in 
(Figure 3.10 (b) and (f)). The apatite formation with the G10 100-400 µm in SBF 
(Figure 3.10 (f)) was faster than with the G10 <38 µm (Figure 3.10 (b)).  
Regarding the influence of the glass particle size on the apatite formation in Tris 
buffer, the 45S5 has the same trend as in SBF, where the apatite formation is faster 
with 45S5 100-400 µm than with <38 µm. The 45S5 100-400 µm forms apatite at 
approximately 8 hours immersion in Tris buffer (Figure 3.6 (b)). Whereas, the 45S5 
<38 µm forms apatite after 72 hours immersion in Tris buffer as investigated by the 
Mneimne et al. study (Mneimne, 2014). 
Moreover, both 45S5 and G10 glasses with large particles 100-400 µm seem to 
have the same rate of apatite formation. Despite the fact that the G10 glass should 
accelerate the apatite formation rate due to its higher phosphate concentration as 
reported in other studies (O’Donnell et al., 2009, Mneimne et al., 2011). Hence, the 
particle size of bioactive glass has bigger effect on the rate of apatite formation on 
glass dissolution than the glass composition in this case.  
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Figure ‎3.11 XRD patterns before and after immersion in SBF were plotted as a 
function of time for a) 45S5 PS <38 µm, b) G10 PS <38 µm, c) 45S5 PS 38-100 µm, d) 
G10 PS 38-100 µm, e) 45S5 PS 100-400 µm and f) G10 PS 100-400 µm. 
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Figure 3.11 illustrates the specific feature of apatite crystal phase in XRD traces as 
identified by Bragg peaks labelled at approximately 26° and 32° 2 θ, which overlap 
the amorphous broad halo of unreacted glass. These peaks 26° and 32° Two-Theta 
which reference the apatite formation are initially developed as nanocrystals. 
Therefore, these peaks cannot be easily distinguished at earlier reaction time due to 
their broad and weak XRD intensities. However, with progressing immersion time, 
these nanocrystals grow in size as more apatite precipitation occurs, resulting in 
sharper and more intense diffraction peaks as expected based on the Scherrer 
equation for crystal size analysis (Cullity and Weymouth, 1957).  
The G10 glass with <38 µm shows more intense diffraction peaks labelled 
approximately at 26° and 32° Two-Theta. Whereas 45S5 does not show such sharp 
apatite diffraction lines as in (Figure 3.11 (a)) in spite of the emergence of 
amorphous silica gel layer 20-24° Two Theta degrees. The appearance of silica gel 
layer confirmed the glass degradation in SBF. The faster rate of apatite formation 
which can be observed clearly with G10 glass (Figure 3.11 (b)) is attributed to the 
high phosphate content of G10 glass (O’Donnell et al., 2009, Mneimne et al., 2011).    
Figure 3.11 (e) and (f) of 45S5 and G10 respectively do not reveal intense 
diffraction peaks of apatite. The reason behind this weakness in XRD intensity can 
be attributed to the significant effect of coarse particles size (100-400µm) to 
decelerate the glass dissolution rate in SBF. The 45S5 and the G10 glasses might 
not dissolve completely. Therefore, the XRD patterns cannot detect the apatite 
peaks easily, exhibiting this weak intensity due to the presence of residual 
amorphous halo of the unreacted glass. Conversely, the 45S5 and the G10 were 
dissolved completely due to their fine particles size <38 µm as shown in Figure 3.11 
(a) and (b) and the apatite crystal phase was well-defined. The FTIR spectra in 
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Figure 3.10 are supported by the XRD patterns in Figure 3.11 with respect to the 
significant influence of particles size on the glass bioactivity. 
 




Figure ‎3.12 The pH profile in SBF for the three fractions of particles size (<38 µm, 38-
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Figure 3.12 (a) and (b) demonstrates the pH behaviour versus time after immersion 
in SBF including three fractions of particle size (<38 µm, 38-100 µm and 100-400 
µm) for (a) 45S5 and (b) G10. For both 45S5 and G10, the highest pH rise seems 
clearly to be associated with fine particles size (<38 µm), followed by the pH of 
medium particle size (38-100 µm). However, the lowest pH rise is associated with 
large particle size (100-400 µm). 
As a general trend, the pH rise of the G10 glass was less than the pH rise of 45S5 
with all fractions, and this property can be attributed to the effect of the higher 
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Figure ‎3.13 The percentage of the calcium ion concentration measured after the 
immersion of the glass powder (45S5 and G10) in SBF up to 24 hours. All the data 
were plotted as a function of time for three fractions of particles size (<38 µm, 38-100 
µm and 100-400 µm), (a) 45S5 and (b) G10.  
   
In order to understand the extent of the bioactive glass dissolution, the release of 
Ca2+ ion in SBF (Figure 3.13 (a) and (b)) is expressed as percentage dissolution. 
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SBF and the maximum Ca2+ concentration, assuming that the glass is dissolved 
completely in SBF.  
As expected, Figure 3.13 (a) and (b) revealed that the highest calcium ion release 
was associated with the fine particles size for both the 45S5 and the G10 due to the 
rapid glass dissolution rate associated with fine particles size. The calcium ion 
release of G10 glass <38 µm (Figure 3.13 b) dropped quickly after 6 hours 
treatment with SBF compared to the 45S5 <38 µm (Figure 3.13 a). This behavior 
might be attributed to much more apatite formed with G10, which consumed more 
calcium ions, whereas only a small amount of calcium ion was consumed to form 
apatite in 45S5. Therefore, the higher release of Ca2+ in SBF results in the pH 
increases more rapidly. The lower release of Ca2+ on immersion of the coarser 
particles in SBF reduces the rapid pH rise. 
Overall, based on the above findings, it can be concluded that the large glass 
particles may slow down the release of Ca2+ and Na+ ions from the glass into the 
solution via the ion-exchange process. The lower release of Ca2+/Na+ on immersion 
of the coarser particles in SBF reduces the rapid pH rise, thereby enabling earlier 
apatite formation. Whilst, the fine particle size generates a rapid pH rise due to 
faster ion release. The rapid pH rise suppresses the ion exchange process of glass 
dissolution, thus, slowing down any further glass dissolution and retarding apatite 
formation. Subsequently, the glass dissolution rate was the lowest for the largest 
particle size and a coarse particle size decreased a rapid pH rise & accelerated 
apatite formation.  
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4 Biodegradable Silicate/Phosphate Glass Mixtures 




The high alkaline pH generated by PerioGlas® can facilitate the growth of 
periodontopathic bacteria such as P.gingivalis, which grows optimally at higher pH ≈ 
8.3 (Takahashi and Schachtele, 1990). Furthermore, this high alkaline pH inhibits 
the apatite formation by suppressing the ion exchange process of bioactive glass 
dissolution (Bingel et al., 2015). The high pH also retards bone formation through 
the inhibition of osteoblast activity and suppression of osteogenic 
differentiation/proliferation in the local biological environment (Monfoulet et al., 
2014). Therefore, the aim of this PhD project was to address the problem of 
PerioGlas® by mixing two degradable glasses, silicate (S-glass) and phosphate (P-
glass). The phosphate glass as it degrades in physiological body fluid results in an 
acidic pH whilst the silicate bioactive glass results in an alkaline pH. The extreme 
pH rise generated by silicate glass can potentially be regulated by mixing the two 
glasses together to tailor the pH evolution and adjust it to the biological 
environment. 
Strontium has been added to the phosphate glass since strontium upregulates 
osteoblasts (Gentleman et al., 2010) and is also bactericidal against some bacteria 
including P. gingivalis (Liu et al., 2016). It provides radio-opacity enabling the 
dissolution process to be followed clinically by X-rays.   
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4.2 Rationale of Silicate/Phosphate Glass Mixtures Design: 
 




The design strategy of glass mixtures used in this research is based on mixing one 
silicate glass (S-glass) composition with three compositions of phosphate glass (P-
glass). Table 4.1 shows the compositions of silicate glass with network connectivity 
of 2.1 and all three phosphate glasses in mole percent. The silicate glass does not 
contain phosphate, potassium or strontium in its composition, thus these ions arise 
only from phosphate glass. Phosphate glass composition P1 contains phosphate, 
strontium and potassium without calcium, whilst phosphate glass P2 contains 
phosphate, potassium and calcium with no strontium. The design of phosphate 
glass P3 is composed of all these elements with various concentrations with both 
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calcium and strontium. In terms of the particle size, the silicate glass has a coarse 
particle size (100-400 µm), whereas all three phosphate glasses have a fine particle 
size (<38 µm). The phosphate glass will be dissolved first due to its fine particles 
followed by coarser silicate glass particles dissolution. Moreover, the large particles 
size of the silicate glass will reduce the silicate glass dissolution rate and decrease 
the rapid pH rise as previously discussed in Chapter 3, section 3.4. 
Therefore, it is proposed in this mixture that phosphate glass (P-glass) can dissolve 
initially due to its smaller particles size producing an acidic pH, which inhibits the 
alkaline periodontal bacterial growth. Afterwards, this acidic pH catalyses the 
coarser silicate glass particle dissolution (Bingel et al., 2015), resulting in a smart 
pH modulation which should be favourable for new bone formation.   
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The schematic diagram below (Figure 4.1) below illustrates the essential strategy of 
novel silicate/phosphate glass mixtures: 
 
Figure ‎4.1 Schematic demonstration of the main strategy of the silicate/phosphate 
glass mixtures. The ratios given are by weight. 
 
According to the schematic diagram shown above in Figure 4.1, three 
silicate/phosphate synthetic glass blends were developed, which have never been 
used previously but are thought to be the most promising. These mixtures are SP1, 
SP2 and SP3. Three mixtures were prepared with each of the phosphate glasses 
using the three ratios (10/90, 50/50 and 25/75), where 10% for silicate glass whilst 
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90% for phosphate glass, 50% for each glass and 25% for silicate glass whereas 
75% for phosphate glass, all by weight. As a part of the concept design and in order 
to differentiate the stages of their dissolution in time, the silicate glass has a coarse 
particle size 100-400 µm and the phosphate glass has a small particle size <38 µm. 
The dissolution experiments were performed in Tris buffer solution which does not 
contain any ions to interfere with the ion release analysis. During glass mixture 
dissolution, the ions of phosphate, strontium and potassium with mixture of SP1 
emerge from P1 glass dissolution only; whilst silicate, calcium and sodium ions arise 
only from silicate glass dissolution. With respect to the SP2 mixture, the phosphate 
and potassium ions originate from P2 glass degradation only, whereas silicate and 
sodium ions arise only from silicate glass dissolution. In terms of SP3 mixture the 
phosphate, strontium and potassium ions emerge from P3 glass dissolution only, 
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4.3 Characterisation of Untreated Individual Silicate and 
Phosphate Glasses (Results and Discussion): 
 




Figure ‎4.2 XRD patterns demonstrate that all unreacted glasses (a) silicate glass and 
(b) phosphate glasses P1, P2 and P3 were amorphous. 
 
 
Figure 4.2 (a) and (b) shows that the silicate glass and all three phosphate glasses 
P1, P2 and P3 were amorphous by the absence of sharp Bragg peaks. All patterns 













(a) Silicate glass 















(b) Phosphate glasses 
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reveal broad halos, which was a characteristic feature of an amorphous system, 
indicating the absence of crystallinity of unreacted glasses. 
 
4.3.2 Differential Scanning Calorimetry (DSC) Results: 
 
 
Figure ‎4.3 Showing the correlation between the glass transition temperature Tg (°C) 
as a function of the SrO content (mole %) in the prepared phosphate glasses. 
 
Glass transition temperature values for all the glass are presented in Table 4.1. 
Figure 4.3 demonstrates the glass transition temperature against strontium content 
(mole %). It was clearly observed that there was a linear reduction with an 
increasing strontium content in the prepared phosphate glasses, with the correlation 
coefficient R2 = 0.9994. A similar effect of strontium addition on glass transition of 
the silicate glasses (O’Donnell et al., 2010) can be typically explained by a slightly 
larger cationic size of strontium compared to calcium. This results in slight 
expansion of the glass network and reflects in reduction the glass transition 
temperature. Substitution of strontium for calcium in phosphate glasses is seen to 
result in a decrease in glass transition temperature.  
y = -0.9714x + 396.29 
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P-glass Frit
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Figure ‎4.4 Showing (a) the 31P MAS-NMR spectra of all untreated individual phosphate 
glasses before immersion in Tris buffer and (b) the linear correlation between the SrO 
content (mole%) and the 
31
P chemical shift of Q
2
 metaphosphate species. Asterisks 
show spinning side bands. 
  
y = 0.0579x - 26.571 
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(b) 
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The atomic environment of phosphate in the prepared untreated phosphate glasses 
(P1, P2 and P3) was characterised by the 31P MAS-NMR spectroscopy as 
demonstrated in Figure 4.4 (a). The dominant chemical shift from -24.9 ppm to -26.7 
ppm can be assigned distinctly to the Q2-metaphosphate species in the untreated 
glasses, whilst the chemical shift from -11.5 ppm to -12.4 ppm is assigned to the Q1-
phosphate species. The peaks of Q1-phosphate species were in much smaller 
proportion compared to the dominant Q2 species which was due to the constant 
phosphate ratio of 55 mole% in all three compositions. A small shoulder at ca -40 
ppm on the right-hand side of the Q2 signal corresponds to a minor fraction of the 
Q3-phosphate species. This indicates that the structure of the glasses contains not 
just infinite chains or rings but these fragments can be also partly cross linked. 
Figure 4.4 (b) illustrates the 31P chemical shift of Q2 metaphosphate species as a 
function of the strontium content. It was evident that the correlation between the 31P 
chemical shift of Q2 metaphosphate species and strontium content was linear with 
the coefficient of correlation R2 = 0.964. This chemical shift linearity reveals that the 
substitution of calcium with strontium in Q2-metaphosphate units occurs randomly 
and does not cause any significant change in the glass structure. The only sign of 
mixing cations was observed from the slight change in line width of the Q2 signal. 
The line width is broad for the mixed cation glass composition P3 and becomes 
narrower in the spectra of the P2 and P1 glass.  
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4.3.4 pH Measurement Results: 
 
 
   
 
Figure ‎4.5 The pH behaviour in Tris buffer solution as a function of time for the four 
prepared glasses: (a) silicate glass; (b) P1 phosphate glass; (c) P2 phosphate glass 
and (d) P3 phosphate glass. Additional dashed lines in the Figures corresponds to the 
pH=8.3 (a), which is the optimal pH for growth of P.gingivalis and the pH=7.3 (b-d), 
which corresponds to the average physiological pH.  
 
 
As can be observed in Figure 4.5 (a), the silicate glass dissolution in Tris buffer 
solution generated a dramatic increase in the pH measurements over the time 
periods of the experiment. The highest value of silicate glass pH (pH ≈ 9.12) was 
prominent after 168 hours of immersion time. This highly alkaline pH > 9 is the 
optimum pH for bacterial growth of the virulent P.gingivalis species (Takahashi and 
Schachtele, 1990), which is the main orchestrating bacteria in periodontal disease. 
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Figure 4.5 (b), (c) and (d) respectively revealed that all three phosphate glasses P1, 
P2 and P3 during their dissolution in Tris buffer showed a noticeable decrease in pH 
at the commencement of the experiment. Subsequently, the pH remained quite 
acidic and constant during the residual time of the experiment due to the capacity of 
the buffer solution to neutralise the sharp pH change in solution generated by 
further glass dissolution. This extremely acidic pH was far below the physiological 
pH range which is about 7.35 and this environment is also unfavourable for apatite 
formation.  
The most noticeable drop in the solution pH of the phosphate glasses after 24 hours 
of immersion time was a pH of P2 (pH ≈ 2.11), followed by a pH of P3 (pH ≈ 2.13) 
and the least acidity was the pH of P1 (pH ≈ 2.23). Therefore, it appears that the 
addition of strontium results in a slight increase in pH of the individual phosphate 
glass dissolution. It is possible that a slightly higher alkalinity of strontium cation in 
solution compared to the calcium one has some effect on the pH values. Dissolution 
of the strontium containing phosphate glasses in SBF resulted in higher pH values 
than those that were obtained on dissolution of the calcium only containing 
phosphate glass as reported by Massera et al. (Massera et al., 2013). 
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4.4 Glass Mixtures Characterisation: 
4.4.1 pH Measurement Results: 
 
 
Figure ‎4.6 The pH behaviour in Tris buffer solution as a function of time of three 
different ratios for each glass mixture together with discrete silicate and phosphate 
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Figure 4.6 (a), (b) and (c) demonstrated the pHs trend of all three glass mixtures 
SP1, SP2 and SP3 together alongside their three ratios respectively. The glass 
mixtures SP1, SP2 and SP3 with their three ratios (10/90, 50/50 and 25/75) exhibit 
smart modulation in pH behaviour in between the two undesirable extremes acidic 
and alkaline. It was clearly observed from Figure 4.6 (a), (b) and (c) that the initial 
pH drop can be manipulated by varying the ratios of glass mixtures 10/90, 50/50 
and 25/75. The highest pH drop was with the ratio 10/90 where the phosphate ratio 
was 90%, whereas the less pH drop was observed with the ratio 25/75 followed by 
50/50 which regulated the pH around the physiological range.  
Therefore based on the experimental pH data of glass mixtures provided above, it 
should be taken into account how it would be possible to regulate this pH behaviour 
by varying the composition of these glass mixtures with their ratios.  
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4.5 Glass Mixtures Characterisation with the Ratio 10/90 (Results 
and Discussion):  





Figure ‎4.7 The 31P MAS-NMR spectra (mas=22kHz) of studied glass mixtures with a 
10/90 ratio before and after immersion in Tris buffer were plotted as a function of time 
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Figure 4.7 (a), (b) and (c) illustrates the 31P MAS-NMR spectra of the experimental 
glass mixtures with the 10/90 ratio of SP1, SP2 and SP3 respectively before and 
after immersion in Tris buffer solution up to 7 days. The signal from -24.9 ppm to -
22.2 ppm in glass mixture SP1 corresponds with the chemical shift range of Q2-
metaphosphate species (Kirkpatrick and Brow, 1995, MacKenzie and Smith, 2002). 
A similar signal was identified in the two other glass mixtures, with a range of 
chemical shift signal from -26.7 ppm to -22.6 ppm in mixture SP2 and from -26.3 
ppm to -23.3 ppm in mixture SP3. 
Furthermore, the 31P MAS-NMR spectra revealed another signal from -11.4 ppm to -
7.2 ppm in glass mixture SP1, from -8.3 ppm to -7.6 ppm in mixture SP2 and from -
8.4 ppm to -7.7 ppm in mixture SP3. This chemical shift range corresponds to the 
Q1-phosphate species (Kirkpatrick and Brow, 1995, MacKenzie and Smith, 2002). 
As a general trend, the appearance of Q0-orthophosphate species can be only 
observed in very small amount with glass mixture SP1 10/90 at 3 days of immersion 
in Tris buffer at the peak position ≈ 2 ppm (Kirkpatrick and Brow, 1995, MacKenzie 
and Smith, 2002). In contrast, there was no visible or detectable presence of Q0-
orthophosphate species neither in glass mixture SP2 nor SP3. 
The degradation of glass mixtures SP1, SP2 and SP3 was indicated by the 
transformation of phosphate in glass mixture from Q2- species into Q1-phosphate 
species. This degradation can be readily seen in Figure 4.7 (a), (b) and (c) for all 
glass mixtures SP1, SP2 and SP3 respectively; the amount of Q2 decreases with 
time, whereas the amount of the Q1 signal increases. The 31P MAS-NMR spectra 
revealed that the fastest glass mixture degradation occurred with the ratio 10/90 
was with SP2 (no strontium) followed by SP1 (no calcium), which was less 
degradable than SP2, whereas the slowest degradation was observed in SP3. This 
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could be seen from the comparison of the 7 days spectra between all three glass 
mixtures. The mixture SP3 have a dominant Q2 signal in the 7 days spectrum, 
whereas the mixture SP2 showed dominant Q1 signal in the spectrum, with the 
mixture SP1 showing significant both Q1 and Q2 signals. In the future work these 
spectra will be deconvoluted and integral intensities values will be obtained for more 
detailed comparison.  
It is of interest to know that the emergence of Q0-orthophosphate species in the 
glass mixture SP1 10/90 was likely to be as a result of precipitation of phosphate 
from the solution. Most probably this precipitation results from the hydrolysis of 
P―O―P bond of the Q1-phosphate species to produce orthophosphate ions PO4
3- 
as reported in the published literature (Gao et al., 2004) and (Bunker et al., 1984). 
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Figure ‎4.8 The FTIR spectra of studied glass mixtures with a 10/90 ratio before 
(untreated) and after immersion in Tris buffer for different time period indicated in 
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Figure 4.8 revealed three main bands in the spectra. The two bands at 890 and 
1280 cm-1 are assigned to the Q2 metaphosphate stretching vibrational band 
(Moustafa and El-Egili, 1998, Ilieva et al., 2001, Patel et al., 2017). The band at 
approximately 1095 cm-1 is assigned to the Q1-phosphate absorption band 
(Moustafa and El-Egili, 1998, Ilieva et al., 2001, Patel et al., 2017). It can be clearly 
observed that the fastest glass mixture degradation in Tris buffer solution with the 
ratio 10/90 is SP2 mixture (no strontium), indicating by: (i) the gradual 
disappearance of Q2 metaphosphate vibrational band over the entire time of 
experiment and also (ii) the gradual emergence of Q1-phosphate absorption band 
as a function of dissolution time.  
Furthermore, FTIR did not show any significant difference in dissolution behaviour 
of glass mixtures SP1 10/90 and SP3 10/90 as given in Figure 4.8 (a) and (c) 
respectively. Even though the glass mixture SP3 after 7 days immersion in Tris 
buffer dissolved faster than SP1 as detected by decreasing the intensity of the Q2 
metaphosphate stretching bands compared to the equivalent bands of SP1 mixture 
after 7 days immersion in Tris buffer. However, both SP1 and SP3 10/90 mixtures in 
Figure 4.8 (a) and (c) respectively exhibited similar intensities in the appearance of 
the Q1-phosphate absorption band over the immersion time points of the 
experiment. Thus, the FTIR spectra in Figure 4.8 (b) supported the results of the 31P 
MAS-NMR spectra in Figure 4.7 (b), which were discussed in the previous section 
above.  
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Figure ‎4.9 The pH behaviour in Tris buffer solution as a function of time of three 
experimental glass mixtures with a 10/90 ratio together with the expected pH value 
from each glass mixture based on the ratio 10/90 and pH value of each studied 
individual phosphate glass: (a) pH of SP1 & P1; (b) pH of SP2 & P2 and (c) pH of SP3 
& P3. The data of predicted pH based on linear combination of the pH values for the 
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As a general trend, Figures 4.9 (a), (b) and (c) showed the pH behaviour of the 
studied glass mixtures SP1, SP2 and SP3 respectively with the ratio 10/90 after 
different time points of immersion in Tris buffer alongside their expected pH values. 
The latter was calculated from the pH measurements of the individual silicate and 
phosphate glasses P1, P2 and P3 in Tris buffer taking into account the ratio of the 
glasses. 
The most noticeable drop in the solution pH of glass mixture at the beginning of the 
experiment was a pH of SP3 10/90 (pH ≈ 2.75) as shown in Figure 4.9 (c). Followed 
by the pH SP2 10/90 (pH ≈ 2.89) as in Figure 4.9 (b) and the least acidity was the 
pH of SP1 10/90 (pH ≈ 4.59). 
Based on these pH results, it became clear that the acidity of phosphate glass can 
be regulated by mixing the phosphate glass with the silicate glass. Additionally, the 
pH behaviour of the silicate/phosphate glass mixture can be modulated accurately 
by varying the composition of these mixtures. 
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Figure ‎4.10 The phosphorus concentrations in ppm in Tris buffer solution plotted as a 
function of time for the experimental glass mixtures with a 10/90 ratio together. 
Predicted phosphorus release is estimated from the phosphorus release from each 
studied individual phosphate glass: (a) P from P1 & SP1; (b) P from P2 & SP2 and (c) 
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Figure 4.10 (a), (b) and (c) represents the phosphorus release after immersion in 
Tris buffer solution at different time points with respect to the 10/90 ratio for the 
three glass mixtures SP1, SP2 and SP3 respectively. Thereby, (a) represents the 
phosphorus originating from the individual phosphate glass (P1) in Tris buffer in 
addition to the phosphorus release in Tris of 10/90 SP1 mixture as well as the 
predicted phosphorus release from the P1 based on the 10/90 ratio. Likewise, (b) 
represents the phosphorus emerging from the individual phosphate glass (P2) in 
Tris buffer in addition to the phosphorus release in Tris of 10/90 SP2 mixture as well 
as the predicted phosphorus release from the P2 based on the 10/90 ratio. Thus, (c) 
represents the phosphorus release from the individual phosphate glass (P3) in Tris 
buffer in addition to the phosphorus release in Tris from 10/90 SP3 mixture as well 
as the predicted phosphorus release from the P3 based on the 10/90 ratio. 
As can be observed from the Figure 4.10 (a), (b) and (c), the phosphorus release 
from the experimental data of SP2 followed closely the predicted patterns, whereas 
there was a massive deviation between the experimental phosphorus release from 
SP3 and the predicted ones. The intermediate deviation between the experimental 
phosphorus release and the predicted values were observed for the SP1.   
Regardless of the fact that all three compositions contain the same amount of 
phosphate, the phosphorus release in Tris buffer (measured in ppm) was much 
higher in the glass mixture SP2. The relatively low phosphorus release was 
associated with the glass mixture SP1, whilst the least phosphorus release was 
from the glass mixture SP3.  
These obtained phosphorus concentration data are in good agreement with the 31P 
MAS-NMR spectra in Figure 4.7 (a), (b) and (c) as well as the FTIR results in Figure 
4.8 (a), (b) and (c), where the fastest dissolution was observed in glass mixture 
SP2, the SP1 showed the lower rate of dissolution, whilst the slowest degradation 
Page | 137  
 
was seen in mixture is SP3. The faster dissolution seen in NMR spectra resulted in 
the highest concentration of phosphorus in solution (Figure 4.10 (b)). 
The drop in the phosphorus concentration after 24 hours immersion as in Figure 
4.10 (a) was in good consistency with the 31P MAS-NMR spectra in Figure 4.7 (a). 
The reduction of the measured concentration of phosphorus in solution can be 
accounted to the uptake of phosphorus from solution and precipitation of the Q0-
orthophosphate species. The latter was detected in 31P MAS-NMR spectrum of the 
glass mixture SP1 10/90 as the peak at the position ≈ 2 ppm at 3 days immersion in 











Figure ‎4.11 The potassium ion concentrations in ppm in Tris buffer solution plotted as 
a function of time for the experimental glass mixtures with a 10/90 ratio. Predicted 
potassium ion release is estimated from the potassium release from each studied 
individual phosphate glass: (a) K from P1 & SP1; (b) K from P2 & SP2 and (c) K from 
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Figure 4.11 (a), (b) and (c) exhibits the concentration of potassium ion measured in 
ppm as a function of dissolution time in Tris buffer solution for the three glass 
mixtures SP1, SP2 and SP3 respectively all with the 10/90 ratio. 
Thereby, (a) demonstrates the potassium ion release from the individual phosphate 
glass (P1) after immersion in Tris buffer (blue diamonds), the release of potassium 
ion in Tris buffer of 10/90 SP1 mixture (red squares) as well as the predicted 
potassium ion release from the P1 depending on the 10/90 ratio (green triangles). 
Similarly and using the same markers, (b) illustrates the potassium ion release from 
the individual phosphate glass (P2) in Tris buffer, the potassium ion release in Tris 
immersion of 10/90 SP2 mixture as well as the predicted potassium ion release from 
the P2 based on the 10/90 ratio. Figure 4.11 (c) represents the potassium ion 
release from the individual phosphate glass (P3) in Tris buffer in addition to the 
potassium ion release in Tris of 10/90 SP3 mixture as well as the predicted 
potassium ion release from the P3 based on the 10/90 ratio. 
From the Figure 4.11 (a), (b) and (c), the potassium ion release from the 
experimental patterns of SP1 and SP2 with the ratio 10/90 follows well the predicted 
behaviour, whereas there was a significant variation between the experimental 
potassium ion release from SP3 10/90 and the predicted ones. Thereby, the highest 
potassium ion release in Tris buffer was in conjunction with the glass mixtures SP1 
and SP2 10/90, whilst the lowest potassium ion release emerged from the glass 
mixture SP3 10/90. 
It is of interest to note that similarly to phosphorus release, the trend of potassium 
ion release data was also in good consistency with the 31P MAS-NMR spectra in 
Figure 4.7 (a), (b) and (c) as well as the FTIR results in Figure 4.8 (a), (b) and (c). 
The fastest dissolution was observed in the SP2 10/90 and the less degradable was 
SP1 10/90, whilst the slowest dissolving mixture was SP3 10/90. The latter was in 
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agreement with the lowest potassium release from SP3 mixture. The lowest 





Figure ‎4.12 The strontium ion concentrations in ppm in Tris buffer solution plotted as 
a function of time for the experimental glass mixtures with a 10/90 ratio. Predicted 
strontium ion release is estimated from the strontium release from the individual 
phosphate glasses: (a) Sr from P1 & SP1; (b) Sr from P3 & SP3 reduced in the amount 
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Figure 4.12 (a) and (b) exhibits the concentration of strontium ion measured in ppm 
as a function of dissolution time in Tris buffer solution for the glass mixtures SP1 
and SP3 respectively with the 10/90 ratio. 
As mentioned before, there was no strontium in SP2 therefore Figure 4.12 (a) 
displays the strontium ion release from the individual phosphate glass P1, the 
release of strontium ion from 10/90 SP1 mixture as well as the predicted strontium 
ion release from the P1 depending on the 10/90 ratio. Similarly, Figure 4.12 (b) 
illustrates the strontium ion release from the individual phosphate glass (P3), the 
strontium ion release from 10/90 SP3 mixture as well as the predicted strontium ion 
release from the P3 based on the 10/90 ratio. 
From the Figure 4.12 (a) and (b), both patterns of strontium ion release from the 
experimental data of SP1 and SP3 with the ratio 10/90 do not closely follow the 
predicted strontium release, in particular the glass mixture SP3 shows the massive 
deviation between the experimental strontium ion release from SP3 10/90 and the 
predicted ones. Therefore, the maximal strontium ion release is from the glass 
mixture SP1, whereas the minimum strontium ion release is associated with the 
glass mixture SP3.  
The profile of strontium ion release data and in particular the lowest concentration 
values seen in SP3 were in accordance with the 31P MAS-NMR results in Figure 4.7 
(a) and (c) as well as the FTIR results in Figure 4.8 (a) and (c), where the 
spectroscopy investigation indicated that the glass mixture SP3 10/90 was the 
slowest degradable glass mixture. 
  





Figure ‎4.13 The calcium ion concentrations in ppm in Tris buffer solution plotted as a 
function of time for the experimental glass mixtures with a 10/90 ratio; together with 
the predicted calcium ion release based on the ratio 10/90 and calcium ion release 
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It is important to realise that the calcium ion release in the glass mixture SP1 
emerges totally from the silicate glass, whereas the release of calcium ion from the 
glass mixtures SP2 and SP3 arises from both the silicate and phosphate glasses as 
highlighted before in the rationale section 4.2.  
Subsequently, Figure 4.13 (a), (b) and (c) exhibits the concentration of calcium ion 
measured in ppm as a function of dissolution time in Tris buffer solution for the three 
glass mixtures SP1, SP2 and SP3 respectively with the 10/90 ratio. Thereby, Figure 
4.13 (a) demonstrates the calcium ion release from the individual silicate glass after 
immersion in Tris buffer, the release of calcium ion in Tris buffer of 10/90 SP1 
mixture as well as the predicted calcium ion release from the silicate glass 
depending on the 10/90 ratio. Similarly, (b) illustrates the calcium ion release of 
10/90 SP2 mixture in Tris immersion as well as the predicted calcium ion release 
10% from silicate glass plus 90% from phosphate glass P2 based on the 10/90 
ratio. Figure 4.13 (c) represents the calcium ion release in Tris from 10/90 SP3 
mixture as well as the predicted calcium ion release 10% from silicate glass plus 
90% from phosphate glass P3 based on the 10/90 ratio. 
It is of interest to point out from the Figure 4.13 (a), (b) and (c), that the calcium ion 
release from the experimental data of SP2 10/90 roughly followed the predicted 
patterns, whereas there was a prominent difference between the experimental 
calcium ion release from both SP1 and SP3 of the ratio 10/90 and their predicted 
values.  
Considering the absolute values of measured concentration, much higher calcium 
ion release in Tris buffer (measured in ppm) was observed in conjunction with the 
glass mixture SP2 10/90, followed by lower calcium ion release emerging from the 
glass mixture SP3 10/90, with the least calcium ion release arises from the glass 
mixture SP1 10/90.  
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The experimental calcium release behaviour of SP1 10/90 in Figure 4.13 (a) shows 
a particular interesting profile. The initial release profile closely follows the calcium 
release profile from the silicate glass regardless the fact that there was only 10% of 
the silicate glass in the mixture. The depletion in the calcium ion concentration after 
24 hours of immersion in Tris buffer indicated that the consumption of calcium ion 
from solution which was consistent with the precipitation of the Q0-orthophosphate 
species as detected by the 31P MAS-NMR in Figure 4.7 (a).  
Overall, the trend of the highest experimental calcium ion release from SP2 10/90 
was in good agreement with the 31P MAS-NMR spectra in Figure 4.7 (b) as well as 
the FTIR results in Figure 4.8 (b), where the highest dissolution rate was observed 
in SP2 10/90. 
 
  





Figure ‎4.14 The sodium ion concentrations in ppm in Tris buffer solution plotted as a 
function of time for the experimental glass mixtures with a 10/90 ratio. The predicted 
sodium ion release from individual silicate glass based on the ratio 10/90 and sodium 
ion release from the studied individual silicate glass: (a) Na from S & SP1 and (b) Na 
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Another ion which emerges only from silicate glass is the sodium ion. Figure 4.14 
(a), (b) and (c) exhibits the concentration of sodium ion measured in ppm as a 
function of dissolution time in Tris buffer solution for the three glass mixtures SP1, 
SP2 and SP3 respectively with the 10/90 ratio. Figure 4.14 (a) demonstrates the 
sodium ion release from the individual silicate glass after immersion in Tris buffer, 
the release of sodium ion in Tris buffer of 10/90 SP1 mixture as well as the 
predicted sodium ion release from silicate glass depending on the 10/90 ratio. 
Likewise, (b) illustrates the sodium ion release from the individual silicate glass in 
Tris buffer, the sodium ion release from 10/90 SP2 mixture in Tris immersion as well 
as the predicted sodium ion release from the silicate glass based on the 10/90 ratio. 
Figure 4.14 (c) represents the sodium ion release from the individual silicate glass in 
Tris buffer in addition to the sodium ion release in Tris of 10/90 SP3 mixture as well 
as the predicted sodium ion release from the silicate glass based on the 10/90 ratio. 
It can be observed from the Figure 4.14 (a), (b) and (c), that all the patterns of 
sodium ion release from the experimental data of SP1, SP2 and SP3 with the ratio 
10/90 do not follow the predicted sodium release and are much closer to the profile 
of the silicate glass on its own. The greatest amount of sodium ion release in Tris 
buffer is in conjunction with the glass mixture SP3 10/90, whilst the sodium ion 
release arising from both glass mixtures SP1 10/90 and SP2 10/90 is lower and 
quite similar to each other as a function of dissolution time. 





Figure ‎4.15 The silicon concentrations in ppm in Tris buffer solution plotted as a 
function of immersion time for the experimental glass mixtures with a 10/90 ratio 
together with the predicted silicate ion release from individual silicate glass based on 
the ratio 10/90 and silicate ion release from individual silicate glass: (a) Si from S & 
























































































Page | 148  
 
Similar to sodium ion, silicon was another species that emerged only from the 
silicate glass as seen in Figure 4.15 (a), (b) and (c). Silicon species was plotted for 
each of three mixtures in comparison with release from silicate glass alone and 
predicted values based on 10/90 ratio in this Figure.  
It can be observed from the Figure 4.15 (a), (b) and (c) that the experimental 
concentration of silicon measured in SP1, SP2 and SP3 mixtures with the ratio 
10/90 are deviated distinctly from the predicted silicon release data. In particular the 
glass mixture SP3 where the deviation between the experimental silicon release 
from SP3 and the predicted ones is well-defined. Therefore, the greater amount of 
silicon release in Tris buffer is generated from the glass mixture SP3 10/90 as a 
function of dissolution time, followed by the lower amount of silicon release coming 
from the glass mixture SP1 10/90, and the least silicon release seen from the glass 
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4.6 Glass Mixtures Characterisation with the Ratio 25/75 (Results 
and Discussion):  





Figure ‎4.16 The 31P MAS-NMR spectra (mas=22kHz) of studied glass mixtures with a 
25/75 ratio before and after immersion in Tris buffer were plotted as a function of time 
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Figure 4.16 (a), (b) and (c) illustrates the 31P MAS-NMR spectra of the experimental 
glass mixtures with the 25/75 ratio of SP1, SP2 and SP3 respectively before and 
after immersion in Tris buffer solution as a function of time up to 7 days. The 
chemical shift range from -25.2 ppm to -20.7 ppm in glass mixture SP1 was 
assigned to the Q2-metaphosphate species. The signals from -26.7 ppm to -21.7 
ppm in mixture SP2 and from -26.2 ppm to -21.5 ppm in mixture SP3 similarly were 
assigned to the Q2-metaphosphate speciation (Kirkpatrick and Brow, 1995, 
MacKenzie and Smith, 2002). 
The peaks observed in the 31P MAS-NMR spectra were from -8.0 ppm to -6.2 ppm) 
in glass mixture SP1, from -8.8 ppm to -7.5 ppm in mixture SP2 and from -7.7 ppm 
to -7.1 ppm in mixture SP3. These signals were assigned to the chemical shift range 
of the Q1-phosphate species (Kirkpatrick and Brow, 1995, MacKenzie and Smith, 
2002). 
In Figure 4.16 (a) and (b), the spectra of the glass mixtures SP1 and SP2 at early 9 
hours of immersion in Tris buffer solution revealed a peak at the position of around 
2 ppm. This corresponded to the emerging Q0-orthophosphate species (Kirkpatrick 
and Brow, 1995, MacKenzie and Smith, 2002). Similarly, SP3 mixture revealed a 
small signal at 3 ppm at the early 6 hours immersion in Tris buffer as in Figure 4.16 
(c), which also corresponded to precipitation of the Q0-orthophosphate species.  
As stated previously, the degradation of glass mixtures SP1 25/75, SP2 25/75 and 
SP3 25/75 was indicated by the transformation of phosphate in glass mixture from 
Q2-metaphosphate species into Q1-phosphate species. This degradation can be 
readily seen in Figure 4.16 (a), (b) and (c) for all glass mixtures SP1, SP2 and SP3 
respectively. However, the 31P MAS-NMR spectra in Figure 4.16 (a), (b) and (c) 
reveal that all three glass mixtures SP1, SP2 and SP3 with the ratio 25/75 have 
relatively similar behaviour of glass degradation rate in Tris buffer solution. 
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The most significant finding which was observed with the ratio 25/75 was the faster 
degradation rate of mixture SP1 compared to its degradation rate with the 10/90 
ratio as demonstrated by the gradual conversion of the Q2-metaphosphate species 
into the Q1-pyrophosphate species. 
Similar observation can be seen with the glass mixture SP3 25/75 indicated by rapid 
degradation of the Q2-metaphosphate species and transformed into the Q1-
phosphate species which was more pronounced at the ratio 25/75 than the ratio 
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Figure ‎4.17 The FTIR spectra of studied glass mixtures with a 25/75 ratio before and 
after immersion in Tris buffer were plotted as a function of time for: (a) SP1 mixture, 
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The FTIR spectra in Figure 4.17 were similar to the spectra observed in the 10/90 
mixture as described earlier. Similarly, three signals were identified in the spectrum 
of the glass mixture. The FTIR spectra showed a reduction of the band at 
approximately 1280 cm-1, which was Q2 metaphosphate vibrational frequency 
(Moustafa and El-Egili, 1998, Ilieva et al., 2001, Patel et al., 2017) with gradual 
emergence of the band at ≈ 1095 cm-1, which was the Q1 absorption band, 
(Moustafa and El-Egili, 1998, Ilieva et al., 2001, Patel et al., 2017).  
Overall, the FTIR data revealed that the rate of glass mixtures degradation of SP1, 
SP2 and SP3 with the ratio 25/75 was to some extent similar to each other in Tris 
buffer solution.  
The FTIR spectra in Figure 4.17 (a), (b) and (c) were consistent with the 31P MAS-
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Figure ‎4.18 The pH behaviour in Tris buffer solution as a function of time of three 
experimental glass mixtures with a 25/75 ratio together with the predicted pH value 
from each glass mixture based on the ratio 25/75 and pH value of individual 


























































Page | 155  
 
Figure 4.18 (a), (b) and (c) respectively represents the pH change of the studied 
glass mixtures SP1, SP2 and SP3 with the specific ratio 25/75 as a function of 
immersion time in Tris buffer together with their expected pH values. The latter were 
calculated from pH measurements obtained by dissolving the individual phosphate 
glasses P1, P2 and P3 in Tris buffer solution applying this glass ratio. 
The behaviour of pH change in solution shifted towards the relatively high acidity 
after the first 3 hours of glass mixture SP2 25/75 dissolution in Tris buffer (pH ≈ 
4.54) as shown in Figure 4.18 (b). A neutral/slight acidity in solution within the same 
immersion time was from glass mixture SP3 25/75 where the solution pH was ≈ 
6.91 as in Figure 4.18 (c). Moreover, the pH trend in solution shifted towards the 
neutral/slight alkalinity after 3 hours immersion of glass mixture SP1 25/75 as given 
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Figure ‎4.19 The phosphorus concentrations in ppm in Tris buffer solution plotted as a 
function of time for the experimental glass mixtures with a 25/75 ratio together with 
the predicted phosphorus release from each individual phosphate glass based on the 
ratio 25/75 and phosphorus release from each studied individual phosphate glass: (a) 




































































































Page | 157  
 
Figure 4.19 (a), (b) and (c) represents the release of phosphate ion in Tris buffer 
solution at different time points with respect to the 25/75 ratio for the three glass 
mixtures SP1, SP2 and SP3 respectively. Thereby, (a) represents the phosphorus 
coming from the individual phosphate glass (P1) in Tris buffer in addition to the 
phosphorus release in Tris of 25/75 SP1 mixture as well as the predicted 
phosphorus release from the P1 based on the 25/75 ratio. Likewise, (b) represents 
the phosphorus emerging from the individual phosphate glass (P2) in Tris buffer in 
addition to the phosphorus release in Tris of 25/75 SP2 mixture as well as the 
predicted phosphorus release from the P2 based on the 25/75 ratio. Thus, (c) 
represents the phosphorus release from the individual phosphate glass (P3) in Tris 
buffer in addition to the phosphorus release in Tris from 25/75 SP3 mixture as well 
as the predicted phosphorus release from the P3 based on the 25/75 ratio. 
Generally, as can be observed from the Figure 4.19 (a), (b) and (c), the phosphorus 
release from the experimental data of SP2 25/75 follows closely the predicted 
patterns. The trend of the experimental phosphorus release from SP3 25/75 follows 
the pattern of the predicted values up to the initial 9 hours of immersion and 
afterwards it starts deviating strongly from the predicted phosphorus release. The 
experimental values of the phosphorus release from SP1 25/75 follow the predicted 
profile only up to 3 hours before the phosphorus concentration in solution 
significantly drops.  
The highest level of phosphorus release in Tris buffer (measured in ppm) at the 
initial time points was observed in the glass mixture SP3 25/75. Followed by the 
lower phosphorus release associated with the glass mixture SP2 25/75, whilst the 
minimal phosphorus release was from the glass mixture SP1 25/75.  
A dramatic drop in phosphorus concentration was seen in SP3 25/75 at 9 hours 
immersion results from precipitation of phosphate into the solid phase. The 31P 
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MAS-NMR spectra in Figure 4.16 (c) reveal the emergence of a peak at around 3 
ppm after 6 hours immersion in Tris. This peak corresponds to the Q0-
orthophosphate phosphate speciation. Then, and specifically beyond 24 hours of 
experimental time in Tris, the measured concentration of phosphorus in solution 
seems to plateau during the residual time of the experiment. Thus, the data of 
phosphorus release in Figure 4.19 was in good agreement with the 31P MAS-NMR 














Figure ‎4.20 The potassium ion concentrations in ppm in Tris buffer solution plotted as 
a function of time for the experimental glass mixtures with a 25/75 ratio together with 
the predicted potassium ion release from each individual phosphate glass based on 
the ratio 25/75 and potassium ion release from each studied individual phosphate 
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Figure 4.20 (a), (b) and (c) exhibits the concentration of potassium ion measured in 
ppm as a function of dissolution time in Tris buffer solution for the 25/75 ratio for the 
three glass mixtures SP1, SP2 and SP3 respectively. Thereby, (a) demonstrates the 
potassium ion release from the individual phosphate glass (P1) after immersion in 
Tris buffer, the release of potassium ion in Tris buffer of 25/75 SP1 mixture as well 
as the predicted potassium ion release from the P1 depending on the 25/75 ratio. 
Similarly, (b) illustrates the potassium ion release from the individual phosphate 
glass (P2) in Tris buffer, the potassium ion release in Tris immersion of 25/75 SP2 
mixture as well as the predicted potassium ion release from the P2 based on the 
25/75 ratio. Figure 4.20 (c) represents the potassium ion release from the individual 
phosphate glass (P3) in Tris buffer in addition to the potassium ion release in Tris of 
25/75 SP3 mixture as well as the predicted potassium ion release from the P3 
based on the 25/75 ratio. 
It can be seen from the Figure 4.20 (a), (b) and (c), that the potassium ion release 
from the experimental patterns of SP1, SP2 and SP3 with the ratio 25/75 follows the 
predicted behaviour at the early immersion up to 9 hours. At a longer immersion 
period, there was a deviation between the experimental potassium ion release and 
the predicted release.  
The highest potassium ion release in Tris buffer was observed in glass mixtures 
SP1 and SP2 10/90, whilst the lowest potassium ion release emerged from the 
glass mixture SP3 10/90.  
The amount of potassium ion release in Tris buffer for all glass mixtures SP1, SP2 
and SP3 with the ratio 25/75 appeared to be similar at the initial time points of the 
experiment up to 9 hours. Followed by a moderate deviation between the 
experimental potassium release and the predicted ones over the residual time of the 
experiment. 




Figure ‎4.21 The strontium ion concentrations in ppm in Tris buffer solution plotted as 
a function of time for the experimental glass mixtures with a 25/75 ratio together with 
the predicted strontium ion release from each individual phosphate glass based on 
the ratio 25/75 and strontium ion release from each studied individual phosphate 
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As mentioned before, the glass mixture SP2 does not contain strontium in its 
composition, thus the Figure 4.21 (a) and (b) exhibits the concentration of strontium 
ion release measured in ppm as a function of dissolution time in Tris buffer solution 
regarding the 25/75 ratio for the glass mixtures SP1 and SP3 respectively. 
Thus, Figure 4.21 (a) displays the strontium ion release from the individual 
phosphate glass P1 after immersion in Tris buffer, the release of strontium ion in 
Tris buffer of 25/75 SP1 mixture as well as the predicted strontium ion release from 
the P1 depending on the 25/75 ratio. Similarly, (b) illustrates the strontium ion 
release from the individual phosphate glass (P3) in Tris buffer, the strontium ion 
release in Tris immersion of 25/75 SP3 mixture as well as the predicted strontium 
ion release from the P3 based on the 25/75 ratio. 
Figure 4.21 (a) and (b) revealed that both patterns of strontium ion release from the 
experimental data of SP1 and SP3 with the ratio 25/75 did not follow the predicted 
strontium release. The deviation between the experimental strontium ion release 











Figure ‎4.22 The calcium ion concentrations in ppm in Tris buffer solution plotted as a 
function of time for the experimental glass mixtures with a 25/75 ratio together with 
the predicted calcium ion release from individual silicate & phosphate glasses based 
on the ratio 25/75 and calcium ion release from individual silicate glass: (a) Ca from S 
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Figure 4.22 (a), (b) and (c) exhibits the concentration of calcium ion measured in 
ppm as a function of dissolution time in Tris buffer solution with respect to the 25/75 
ratio for the three glass mixtures SP1, SP2 and SP3 respectively.  
It is of interest to note from the Figure 4.22 (a), (b) and (c), that the calcium ion 
release from the experimental data of SP1, SP2 and SP3 with the ratio 25/75 does 
not follow the predicted patterns. In SP3 there was a prominent difference between 
the experimental calcium ion release and its predicted values. The concentration of 
calcium ion release of glass mixture SP3 25/75 in Tris buffer increased over the 
initial time points of experimental work up to 9 hours, then the concentration 
decreased sharply at the longer immersion time and tended to be plateaued during 
the residual time of the experiment. This drop in concentration indicated the 
consumption of calcium into a solid phase via the precipitation. Therefore, the Q0-
orthophosphate species was detected at the peak position ≈ 3 ppm in the sample at 
the early 6 hours immersion through the 31P MAS-NMR spectra in Figure 4.16 (c).  
The calcium concentration in SP1 follows closely the concentration of calcium found 
on immersion of silicate glass alone, thereby showing much higher concentration 
values at the initial stages of immersion up to 24 hours compared to the predicted 
one (Figure 4.22(a)). The calcium ion release from SP2 with the ratio 25/75 does 
not exhibit such dramatic increase or abrupt drop during the initial time of 
experiment.  
The reduction in calcium ion concentration as in Figure 4.22 (a) and (c) was in good 
agreement with the 31P MAS-NMR spectra in Figure 4.16 (a) and (c) respectively, 
where the Q0-orthophosphate species appeared at the peak position ≈ 3 ppm at the 
early 6 hours immersion in Tris buffer. Thus, the depletion of the measured 
concentration of calcium ion in solution can be accounted to the uptake of calcium 
ion from solution following by its precipitation as orthophosphate. 





Figure ‎4.23 The sodium ion concentrations in ppm in Tris buffer solution plotted as a 
function of time for the experimental glass mixtures with a 25/75 ratio together with 
the predicted sodium ion release from individual silicate glass based on the ratio 
25/75 and sodium ion release from studied individual silicate glass: (a) Na from S & 
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Figure 4.23 (a), (b) and (c) presents the concentration of sodium ion measured in 
ppm as a function of dissolution time in Tris buffer solution regarding the 25/75 ratio 
for the three glass mixtures SP1, SP2 and SP3 respectively.  
As can be seen from the Figure 4.23 (a), (b) and (c), that all the patterns of sodium 
ion release from the experimental data of SP1, SP2 and SP3 with the ratio 25/75 
follow the release data measured on silicate glass immersion on its own rather than 
the predicted values for the mixtures. 
 
  





Figure ‎4.24 The silicon concentrations in ppm in Tris buffer solution plotted as a 
function of immersion time for the experimental glass mixtures with a 25/75 ratio 
together with the predicted silicon release from individual silicate glass based on the 
ratio 25/75 and silicon release from studied individual silicate glass: (a) Si from S & 
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Figure 4.24 (a), (b) and (c) shows the concentration of silicon measured in ppm as a 
function of dissolution time in solution regarding the 25/75 ratio for the three glass 
mixtures SP1, SP2 and SP3 respectively. 
The silicon concentration in solution of the SP2 mixture seems to be close to the 
predicted values. The other two mixtures show some deviations between the 
experimental and predicted values especially for the longer duration of immersion. 
The experimental values of concentration were higher than the predicted in SP3 and 
further above in SP1 mixture. 
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4.7 Glass Mixtures Characterisation with the Ratio 50/50 (Results 
and Discussion): 





Figure ‎4.25 The 31P MAS-NMR spectra (mas=22kHz) of studied glass mixtures with a 
50/50 ratio before and after immersion in Tris buffer were plotted as a function of time 
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Figure 4.25 (a), (b) and (c) shows the 31P MAS-NMR spectra of the experimental 
glass mixtures with the 50/50 ratio of SP1, SP2 and SP3 respectively before and 
after immersion in Tris buffer solution as a function of time up to 7 days. At the early 
immersion time, the dominant signal in the glass mixture SP1 50/50 spectra was at 
the position from -24.9 ppm to -20.0 ppm. This is the chemical shift range of Q2-
metaphosphate species (Kirkpatrick and Brow, 1995, MacKenzie and Smith, 2002). 
Similarly, the signal at the position from -26.4 ppm to -21.2 ppm in the mixture SP2 
50/50 spectra and at the position from -26.5 ppm to -21 ppm in the mixture SP3 
50/50 spectra corresponds to the Q2-metaphosphate speciation. 
In addition, 31P MAS-NMR spectra show signal at the position from -8.5 ppm to -6.1 
ppm in glass mixture SP1 50/50, from -8 ppm to -6.5 ppm in the SP2 50/50 mixture 
and from -8.1 ppm to -6.2 ppm in the SP3 50/50 mixture. All these are assigned to 
the Q1-phosphate (Kirkpatrick and Brow, 1995, MacKenzie and Smith, 2002). 
The minor 31P signal at around 2ppm was detected in the spectra of all three glass 
mixtures. This is assigned to the Q0-orthophosphate species (Kirkpatrick and Brow, 
1995, MacKenzie and Smith, 2002), which are assumed resulting from precipitation 
from the solution phase. This species are seen in the spectra of the 24 hours 
sample of the SP1 50/50 and much earlier at 9 and 6 hours of the SP2 50/50 and 
SP3 50/50 mixtures.  
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Figure ‎4.26 The FTIR spectra of studied glass mixtures with a 50/50 ratio before and 
after immersion in Tris buffer were plotted as a function of time for: (a) SP1 mixture, 
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Figure 4.26 shows the FTIR spectra of the three glass mixtures with the 50/50 ratio. 
Similar to the results on the 10/90 and 25/75 mixtures, three main bands were 
identified in the spectra. The band at approximately 1280 cm-1 is assigned to the Q2-
metaphosphate vibrational frequency (Moustafa and El-Egili, 1998, Ilieva et al., 
2001, Patel et al., 2017). This feature gradually disappears with time. The 
absorption band at approximately 1095 cm-1 is assigned to the Q1-pyrophosphate 
(Moustafa and El-Egili, 1998, Ilieva et al., 2001, Patel et al., 2017). This band 
emerges over the entire time of experiment. In other words, the phosphate in glass 
mixtures transforms gradually from Q2 speciation to Q1 speciation i.e. the Q1 forms 
at the expense of Q2 as a function of dissolution time. These FTIR results show that 
three 50/50 mixtures exhibit similar rate of degradation.  
Thus, the FTIR spectra were consistent with the 31P MAS-NMR spectra 
observations as described above. 
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Figure ‎4.27 The pH behaviour in Tris buffer solution as a function of time of three 
experimental glass mixtures with a 50/50 ratio together with the predicted pH value 
from each glass mixture based on the ratio 50/50 and pH value of each studied 



























































Page | 174  
 
Figure 4.27 (a), (b) and (c) respectively demonstrates the pH change of the 
experimental glass mixtures SP1, SP2 and SP3 with the specific ratio 50/50 as a 
function of immersion time in Tris buffer together with their expected pH values 
which were calculated from the pH of the individual phosphate glasses P1, P2 and 
P3 in Tris buffer solution over the entire time of experiment. 
As a general trend, the pH in solution appeared to remain around neutral and/or 
basic after immersion of all the glass mixtures SP1 50/50, SP2 50/50 and SP3 
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Figure ‎4.28 The phosphorus concentrations in ppm in Tris buffer solution plotted as a 
function of time for the experimental glass mixtures with a 50/50 ratio together with 
the predicted phosphorus release from each individual phosphate glass based on the 
ratio 50/50 and phosphorus release from each studied individual phosphate glass: (a) 
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Figure 4.28 (a), (b) and (c) illustrates the concentration of phosphorus measured in 
ppm as a function of dissolution time in Tris buffer solution for the three glass 
mixtures SP1, SP2 and SP3 with 50/50 ratio respectively. 
It can be seen from the Figure that the phosphorus release from the SP2 and SP3 
50/50 follows the predicted data at initial time points up to 9 hours, then the 
experimental data starts deviating from the predicted values. In SP1 50/50 the 
experimentally obtained phosphorus release does not follow the predicted patterns 
and remains lower than the predicted values.  
The observed deviations between the experimental phosphorus release and the 
predicted ones in all 50/50 mixtures was likely to be related to the precipitation of 








   
 





Figure ‎4.29 The potassium ion concentrations in ppm in Tris buffer solution plotted as 
a function of time for the experimental glass mixtures with a 50/50 ratio together with 
the predicted potassium ion release from each individual phosphate glass based on 
the ratio 50/50 and potassium ion release from each studied individual phosphate 
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Figure 4.29 (a), (b) and (c) displays the level of potassium ion release measured in 
ppm as a function of dissolution time in Tris buffer solution for the three glass 
mixtures SP1, SP2 and SP3 all with the 50/50 ratio respectively. 
The experimental concentration patterns show that the potassium ion release 
follows closely the predicted behaviour over the entire time of the experiment. The 

















Figure ‎4.30 The strontium ion concentrations in ppm in Tris buffer solution plotted as 
a function of time for the experimental glass mixtures with a 50/50 ratio together with 
the predicted strontium ion release from each individual phosphate glass based on 
the ratio 50/50 and strontium ion release from each studied individual phosphate 
glass: (a) Sr from P1 & SP1 and (b) Sr from P3 & SP3. 
 
 
Figure 4.30 (a) displays the strontium ion release from the individual phosphate 
glass P1 after immersion in Tris buffer, the release of strontium ion in Tris buffer of 
SP1 50/50 mixture as well as the predicted strontium ion release from the P1. 
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(P3) in Tris buffer, the strontium ion release in Tris immersion of 50/50 SP3 mixture 
as well as the predicted strontium ion release from the P3. 
As can be observed from Figure 4.30 (a) and (b) that the experimental data of 
strontium ion release from SP1 and SP3 with the ratio 50/50 did not follow the 
pattern of the predicted strontium released. The experimentally measured strontium 
concentrations remained lower and almost identical despite the fact that the P3 










Figure ‎4.31 The calcium ion concentrations in ppm in Tris buffer solution plotted as a 
function of time for the experimental glass mixtures with a 50/50 ratio together with 
the predicted calcium ion release from individual silicate & phosphate glasses based 
on the ratio 50/50 and calcium ion release from individual silicate glass: (a) Ca from S 
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Figure 4.31 (a), (b) and (c) displays the concentration of calcium ion measured in 
ppm as a function of dissolution time in Tris buffer of the glass mixtures SP1, SP2 
and SP3 with the 50/50 ratio respectively. 
As demonstrated above in Figure 4.31 (a), (b) and (c), the highest concentration of 
calcium ion release was associated with glass mixtures SP2 and SP3, where the 
pattern of calcium ion release from both mixtures appeared to be very similar. 
Whereas, the lowest calcium concentration in solution was observed in the SP1. 
The experimental calcium release from SP1 50/50 follows the predicted pattern only 
up to 24 hours of the immersion duration then the experimental calcium 
concentration drops substantially compared to the predicted values. There was a 
prominent difference between the experimental calcium concentration in the SP2 
and SP3 and their predicted values. The experimental were lower than the predicted 
values although the initial points of the SP2 and SP3 up to 9 hours had higher 
values where upon the concentration dropped. Afterwards, the calcium 
concentration tended to plateau during the residual time of the experiment. 
This reduction in calcium ion concentration was in good agreement with the 31P 
MAS-NMR spectra in Figure 4.25 (a), (b) and (c), where the depletion of the 
measured concentration of calcium ion in solution was due to the uptake of calcium 
ion from solution to precipitate the Q0-orthophosphate species. 
 





Figure ‎4.32 The sodium ion concentrations in ppm in Tris buffer solution plotted as a 
function of time for the experimental glass mixtures with a 50/50 ratio together with 
the predicted sodium ion release from individual silicate glass based on the ratio 
50/50 and sodium ion release from studied individual silicate glass: (a) Na from S & 
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Figure 4.32 (a), (b) and (c) presents the concentration of sodium ion measured in 
ppm as a function of dissolution time in Tris buffer solution for the three glass 
mixtures SP1, SP2 and SP3 with the 50/50 ratio respectively.  
As can be observed from the Figure 4.32 (a), (b) and (c), the patterns of 
experimental sodium release from all three glass mixtures SP1, SP2 and SP3 with 
the ratio 50/50 did not follow the predicted sodium release. The experimental 
concentration with the mixtures was higher and the values were closer to the values 
on silicate glass dissolution alone. There was little difference between the values for 
all three mixtures. 
 














Figure ‎4.33 The silicon concentration in ppm in Tris buffer solution plotted as a 
function of immersion time for the experimental glass mixtures with a 50/50 ratio 
together with the predicted silicon release from individual silicate glass based on the 
ratio 50/50 and silicon release from studied individual silicate glass: (a) Si from S & 
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Figure 4.33 (a), (b) and (c) illustrates the concentration of silicon measured in ppm 
as a function of dissolution time in solution for the three glass mixtures SP1, SP2 
and SP3 with the 50/50 ratio respectively. 
As a general trend, it can be seen from the Figure 4.33 (a), (b) and (c) that the 
experimental values of the silicon concentration in three glass mixtures follows 














Page | 187  
 
4.8 Overall Discussion: 
 
As an interesting comparison between the ratios 10/90 and 50/50 for all the glass 
mixtures SP1, SP2 and SP3, it can be concluded that all mixtures with the ratio 
50/50 dissolve faster and quicker especially within the first 24 hours of immersion 
time than their equivalents with the ratio 10/90. The faster degradation of all glass 
mixtures with the ratio 50/50 than 10/90 was confirmed by the 31P MAS-NMR 
spectroscopy as in Figure 4.7 (a), (b) and (c), as well as in Figure 4.25 (a), (b) and 
(c). In addition, this faster degradation was also confirmed by FTIR results as in 
Figure 4.8 (a), (b) and (c), as well as in Figure 4.26 (a), (b) and (c). Based on this, it 
can be concluded that the neutral and/or basic pH could be the key factor to 
accelerate the phosphate glass dissolution in the mixture. However, this conclusion 
is not in agreement with the published literature where it has been suggested that 
the phosphate glass dissolution was favoured by an acidic pH (Bunker et al., 1984, 
Gao et al., 2004, Ahmed et al., 2011).  
The 31P MAS-NMR both in Figure 4.16 (a), (b) and (c) and in Figure 4.25 (a), (b) 
and (c) reveal to some extent a similar glass degradation rate in the Tris buffer 
solution involving all glass mixtures SP1, SP2 and SP3 with respect to the ratio 
25/75 and 50/50 respectively, despite the variation of appearance and intensity of 
the Q0-orthophosphate species over the duration of the experiment. 
No significant difference was detected through the 31P MAS-NMR in the dissolution 
behaviour between mixture SP2 10/90 and mixture SP2 25/75, except for the earlier 
emergence of Q1-phosphate species at 3 hours immersion time with the ratio 25/75 
and later at 24 hours with the ratio 10/90. 
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It is worth mentioning that the SP3 glass contains two alkali earth cations calcium 
and strontium and might exhibit the mixed alkali earth effect. This could be revealed 
in the dissolution rate of the glass mixture and therefore should be taken into 
account. The experimental phosphorus and potassium follow their predicted 
patterns in the mixture SP2 10/90. In contrast, both experimental phosphorus and 
potassium deviate from their predicted values in the glass mixture SP3 10/90 (mixed 
alkali). The reason behind this ion release trend can be understood on the basis of 
the influence of the mixed alkali on the dissolution rate of the glass mixture. It is 
possible that this is attributed to the mixed alkali earth phenomenon reflecting the 
lowest glass degradation rate seen under acidic pH and highest degradation rate 
under slightly alkali condition of the 50/50 mixture. 
There was a massive deviation between the experimental calcium ion release of 
SP1 10/90 and its predicted pattern, compared to the slight deviation between the 
experimental calcium ion release of SP1 50/50 and its predicted values. Taking into 
account that calcium ion in glass mixture SP1 emerges only from the silicate glass. 
The reason behind this variation could be attributed to the influence of acidic pH of 
SP1 10/90, which leads to the acceleration of the rate of silicate glass dissolution 
(Bingel et al., 2015) and subsequently producing much more ion release into the 
solution. This feature is advocated by the large percentage of calcium ion release 
from SP1 10/90 (acidic pH) within 24 hours immersion which is ≈ 30 % of calcium 
ion released into the solution as given in Table 4.2 compared to the small 
percentage of calcium ion release from SP1 50/50 (basic pH) within also 24 hours ≈ 
5 % of calcium ion released into the solution. However, this reduction in the calcium 
concentration observed at later time points of immersion can be attributed to the Q0 
calcium phosphate species precipitation as observed in the 31P MAS-NMR spectra. 
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Table ‎4.2 Percentage of calcium ion release from SP1 with both ratios 10/90 and 50/50 











The higher level of sodium ion release in Tris buffer which was released from the 
glass mixture SP3 10/90 can be accounted to the higher acidic pH which was 
generated by glass mixture SP3 10/90 dissolution in Tris buffer (pH ≈ 2.75) as 
shown in Figure 4.9 (c). This could support the published observation that the higher 
acidic media, the higher accelerated silicate glass dissolution (Bingel et al., 2015). 
Therefore, it was expected to find such higher release of sodium ion in solution 
arising from the dissolution of the glass mixture SP3 10/90. 
The amount of sodium ion release in solution was significantly correlated with the 
pH values because of the ion exchange process which in turn required a sodium ion 
to be replaced by a proton H+ according to Hench’s mechanism (Hench, 1991). 
Table 4.3 confirms that around 92% of sodium ion was released from SP3 10/90 
into the solution due to the high acidic pH followed by 48% of sodium ion release 
from SP2 10/90 where the pH was little bit acidic (pH ≈ 2.89) and 37% of sodium ion 







0 0 0 
1 7 3 
3 13 2 
6 16 4 
9 20 5 
24 30 5 
72 14 2 
168 12 1 
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Table ‎4.3 Demonstrating the percentage of sodium ion release with 10/90 ratio from 
SP1, SP2 and SP3 at a corresponding immersion time. The sodium release values in 
percentage are calculated from the experimental values in ppm (plotted in 4.14) taken 
in relation to the total sodium content in silicate glass. 
 
 
It is clearly observed that the presence of both glasses had a certain effect on the 
dissolution of the other glass in the mixtures. Further studies will enable 
investigators to skilfully control the degradation level of both glasses in the mixture 
in order to achieve a desirable pH modulation and generate appropriate release of 
the therapeutic species stimulating bone formation.  
To the best of our knowledge, this is the first systematic study undertaken on mixing 
phosphate and silicate glass. The only other published study on this glass mixture 
was completed by Novajra and his co-workers in 2015 (Novajra et al., 2015). The 
authors reported co-sintering of both the phosphate glass and silicate glass in order 
to produce three-dimensional porous scaffold. However, during the sintering 
process the two glasses silicate and phosphate were crystallised. In contrast, the 
two glasses which have been used in the present study did not sinter and 
crystallise. We have also designed mixture to be composed of the glass particles of 
different particle size. A large particle size 100-400 µm has been used for the 
Time/hours 
       Na% 





0 0 0 0 
1 13 17 28 
3 18 31 35 
6 24 38 36 
9 28 42 30 
24 41 47 81 
72 37 48 93 
168 35 42 89 
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silicate glass and a fine one <38 µm for the phosphate glass as previously 
mentioned in the rationale of glass mixtures design (section 4.2) whereas Novajra 
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5 Novel Silicate/Phosphate Glass Mixtures Designed to 
Function Synergistically With Elevated ALP Enzyme 




The biological marker ALP was used in periodontal research as an indicator for 
periodontal disease. It has been observed that the level of ALP in both saliva and 
gingival crevicular fluid (GCF) was directly proportional to the severity of periodontal 
disease (Bezerra Júnior et al., 2010). This enzyme is released from active 
osteoblast, salivary glands, polymorphonuclear leukocytes, and periodontal bacteria 
(Sanikop et al., 2012). Periodontopathic bacteria such as P. gingivalis and P. 
intermedia have been reported to have intense ALP activity (Shibata et al., 1994). 
Chapter 4 demonstrated the breakdown of the Q2 metaphosphate species in the 
phosphate glass to produce very small amount of the Q0 orthophosphate species 
but with comparatively large amount of the Q1 species. The Q1 pyrophosphate 
species is well-known to inhibit bone mineralisation (Grover et al., 2013). Therefore, 
the application of glass mixtures in Chapter 4 is potentially undesirable for 
periodontal bone regeneration. 
The question addressed in Chapter 5 is whether the elevated level of the ALP in 
GCF within periodontal bony defects can enzymatically hydrolyse the products of 
phosphate glass dissolution, e.g. the Q1 phosphate species, to produce the Q0 
orthophosphate species, which are the mineral phase of natural bone, thereby to 
facilitate the apatite formation and ultimately bone formation. 
Accordingly, the new concept in this Chapter is based on the creation of a unique 
smart material which functions in a synergistic way with the elevated ALP level 
within the periodontal bony defects. In order to achieve this objective, novel silicate 
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and phosphate glasses mixtures were developed to regulate the pH evolution in 
order to: (i) inhibit the alkaline periodontal bacterial growth of the virulent 
P.gingivalis, which is the main orchestrating bacteria in periodontal disease, (ii) 
create a neutral pH environment in the periodontal bony defects for osteoconductive 
bone regeneration and (iii) provide a controlled slightly acidic environment for the 
activity of ALP. The schematic diagram below (Figure 5.1) demonstrates the 
theoretical concept of the new glass mixtures degradation and the process of new 
bone formation by ALP enzyme activity: 
 
Figure ‎5.1 Schematic demonstration of the theoretical concept of the new glass 
mixtures degradation and the process of new bone formation by ALP activity. 
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5.2 Results and Discussion: 
 




Figure ‎5.2 The 31P MAS-NMR spectra of the studied glass mixture SP2 with a 25/75 
ratio before (a) and after (b) treatment with the ALP enzyme plotted for the studied 
immersion time points. The numbers indicate the positions of the peaks in ppm. 
Asterisks show spinning side bands.  
(a) 
(b) 
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Figure 5.2 (a) and (b) illustrates the 31P MAS-NMR spectra of the experimental 
glass mixture SP2 with the 25/75 ratio before and after treatment with the ALP 
respectively. The main signal at the early time point and in the untreated glass was 
observed at the position from -26.7 ppm to -20.8 ppm which corresponds to the 
chemical shift of the Q2-metaphosphate species (Kirkpatrick and Brow, 1995, 
MacKenzie and Smith, 2002). As immersion progresses another signal becomes 
dominant in the spectra with the peak position between -11.5 ppm and -6.8 ppm. 
This corresponds to the Q1-phosphate species (Kirkpatrick and Brow, 1995, 
MacKenzie and Smith, 2002). Another signal between 0 and 3 ppm was observed 
specifically in the spectra of the glasses immersed with ALP. This signal 
corresponds to the orthophosphate species (Kirkpatrick and Brow, 1995, MacKenzie 
and Smith, 2002). It was observed that the Q0 signal appeared stronger in the 
spectra of the samples immersed with ALP rather than those immersed without the 
enzyme. The spectrum of the 24 hours sample with ALP showed the largest amount 
of the orthophosphate. Much sharper appearance of the signal indicated its high 











Figure ‎5.3 The 31P MAS-NMR spectra of the studied glass mixture SP2 with a 50/50 
ratio before (a) and after (b) treatment with the ALP enzyme plotted for the studied 
immersion time points. The numbers indicate positions of the peaks in ppm. 
Asterisks show spinning side bands; the spinning speed of 12 kHz was used for both 
(a) and (b). 
 
Figure 5.3 (a) and (b) shows the 31P MAS-NMR spectra of the solid material from 
the experimental glass mixture SP2 with the 50/50 ratio before and after ALP 
treatment as a function of time up to 7 days. The signal at the position between -
(a) 
(b) 
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26.4 ppm to -20 ppm corresponds to the chemical shift of Q2-metaphosphate 
species (Kirkpatrick and Brow, 1995, MacKenzie and Smith, 2002). The signal at 
the peak position between -7.7 and -6.0 ppm corresponds to the chemical shift of 
the Q1-phosphate species (Kirkpatrick and Brow, 1995, MacKenzie and Smith, 
2002). A minor signal around 2-3 ppm corresponds to the Q0-orthophosphate 
species (Kirkpatrick and Brow, 1995, MacKenzie and Smith, 2002). It was observed 
in all the spectra but specifically it was the clearest in the 7 days of immersion ALP 
sample. Generally, the appearance of the Q0 signal in the sample immersed with 













Page | 198  
 








Figure ‎5.4 The 31P Solution NMR spectra of the solution remained after immersion of 
the studied glass mixture SP2 with a 25/75 ratio (a) without ALP treatment and (b) with 
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Figure 5.4 (a) and (b) illustrates the 31P solution NMR spectra of the solution 
remained after the immersion of the experimental glass mixtures SP2 with the ratio 
25/75 without and with the ALP treatment plotted for the allocated time points 
respectively. 
Three types of the signals were identified in the spectra. The signals with the 
chemical shift between -25.2 ppm and -21.7 ppm were assigned to the Q2-
metaphosphate species (Döhler et al., 2015). The signal between -9.8 ppm and -6.2 
ppm was assigned to the Q1-phosphate species (Döhler et al., 2015). Furthermore, 
the third signal with the position around 3ppm corresponds to the Q0-
orthophosphate species (Döhler et al., 2015). 
Higher amounts of the Q0-orthophosphate species were detected after treatment the 










Figure ‎5.5 The 31P Solution NMR spectra of the solution remained after immersion of 
the studied glass mixture SP2 with a 50/50 ratio (a) without ALP treatment and (b) with 
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Figure 5.5 (a) and (b) shows the 31P solution NMR spectra of the experimental glass 
mixture SP2 with the 50/50 ratio with and without glass mixture treatment with the 
ALP respectively as a function of time up to 7 days. The chemical shift of the Q2-
metaphosphate species and the Q1-phosphtate species in glass mixture SP2 50/50 
appears similar to its equivalent in mixture SP2 25/75. 
It can be observed according to the solution NMR spectra in Figure 5.5 (b) that 
higher amounts of the Q0-orthophosphate species were produced after treatment 
SP2 50/50 with the ALP enzyme compared to the spectra with no enzyme. 
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Figure ‎5.6 The integrals of three types of phosphate seen in the 31P Solution NMR 
spectra of the studied glass mixture SP2 together with and without ALP treatment 
plotted as a function of time for (a) 25/75 ratio and (b) 50/50 ratio.   
(a) 
(b) 
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Figure 5.6 (a) and (b) shows the 31P solution NMR integrals of the experimental 
glass mixture SP2 with the ratios 25/75 and 50/50 ratio with and without treatment 
with ALP as a function of time. With both glass mixture ratios without the enzyme 
treatment, the highest proportion of species released into the solution was Q2-
metaphosphate (≈ 90%). Followed by the Q0-orthophosphate and the lowest 
proportion was the Q1 species. This was in good agreement with the study of 
Ahmed et al. (Ahmed et al., 2005). 
In the presence of the enzyme with both ratios, the proportion of the Q2 species 
decreased and the proportion of the Q0 species increased. There was also a 
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Figure ‎5.7 illustrating the Q species lost or gained after treatment glass mixture SP2 
50/50 ratio with ALP as a function of time. 
 
Figure 5.7 compares the evolution of the decrease in Q2-metaphosphate species, 
with the increase in Q0-orthophosphate species and also shows the decrease in 
both the Q2- and Q1-species together versus time. As can be observed from Figure 
5.7, there were some differences between the proportion of the Q2 species lost (the 
blue points) and the proportion of the Q0 species gained (the orange points) as a 
function of time. In other words, the fraction of Q2 species did not match exactly with 
the Q0 species gained. However, there was a good match between the proportion of 
the (Q2 + Q1) lost (the grey points) and the proportion of the Q0 gained.  
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Figure ‎5.8 illustrating the correlation of Q2 + Q1 loss after ALP treatment versus the Q0 
gained. 
 
Figures 5.8 and 5.9 demonstrate a direct correlation between the fractions as 
identified in Figure 5.7. Thus, Figure 5.8 demonstrates the correlation between the 
(Q2 + Q1) loss against the Q0 gained. This correlation is linear (R2 ≈ 0.97) and the 
slope is (0.986) which is close to (1.0). In other words, with the enzyme treatment 
the amount of (Q2 + Q1) loss was approximately equal to the amount of Q0 gained.   
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Figure 5.9 exhibits the proportion of the Q2 lost against the Q0 gained. As seen the 
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5.2.4 pH Measurement Results: 
 
 
Figure ‎5.10 pH trend in solution plotted as a function of time for both ratios 25/75 and 
50/50 of glass mixture SP2 with and without the ALP treatment. 
 
Figure 5.10 shows the pH trend of the glass mixture SP2 with the ratios 25/75 and 
50/50 against immersion time with and without ALP treatment. It was evident that 
the pH profile with the ALP appeared to be slightly more acidic for both ratios with 



















pH SP2 50/50 No ALP
pH SP2 50/50 With ALP
pH SP2 25/75 No ALP
pH SP2 25/75 With ALP
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5.3 Overall Discussion: 
 
ALP is known for its biological role in cleaving the P-O-P linkages in phosphate 
containing compounds in solution. The results presented above reveal changes 
between three phosphate speciation(s) (Q2-Q1-Q0) in solution which also resulted in 
significant changes between the speciation proportions in solid phase. The 31P 
MAS-NMR spectra in Figures 5.2 and 5.3 show that in the presence of ALP, the Q2-
metaphosphate in the glass decreased much faster than when immersion without 
the ALP. This was noted particularly well in comparison with the spectra for 6 and 
24 hours in Figures 5.2 and 5.3. Simultaneously, a clearly detectable decrease of 
the Q2- and increase of the Q0- species were observed in the solution in presence of 
the ALP. The 24 hour time point of the 25/75 mixture showed a particularly marked 
but consistent result. The solid-state 31P NMR showed a significant fraction of Q0 
appearing in the spectra of the sample with the ALP. The Q0 signals as well as the 
Q2 have a characteristic sharp appearance, which was evident of the crystalline 
character of both species. The solution NMR of this sample presented an unusually 
low Q0 fraction as seen from the Figure 5.4, which was consistent with a significant 
fraction of Q0 crystallising out into the solid phase. However, this massive 
precipitation of Q0 appeared only in one composition and this result requires further 
clarification. 
The type of the Q2 species in the phosphate glasses was largely metaphosphate 
where the proportion of phosphate to cations was equal. The proposed mode of 
phosphate glass dissolution in solutions has been previously reported in a study by 
Ahmed and his co-authors (Ahmed et al., 2005). In Ahmed’s study, the amount of 
the released phosphate species into the solution upon phosphate glass degradation 
has been investigated using ion chromatography. Based on the chromatogram data, 
Ahmed and his co-workers stated that the phosphate species released into the 
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solution after phosphate glass dissolution can be identified as the following: (i) a 
high proportion of the Q2-metaphosphate species which could be either linear chain 
or ring structure (unbranched) and the latter was suggested to be the predominant 
species in solution; followed by (ii) the Q0-orthophosphate species (PO4
3-); and (iii) a 
low proportion of the Q1-pyrophosphate species (dimer P2O7 
4-). This would suggest 
that the Q1 observed from 31P NMR both in solution and the solid state are largely 
from Q1 end groups on Q2 chains rather than from pyrophosphate.  
The solution 31P NMR spectra showed several signals corresponding to each 
phosphate speciation. For instance, the increase in the Q0 speciation can be 
identified as due to a strong increase in the Q0 signal at around 1-2 ppm in both 
mixtures in the presence of ALP. Whereas, another Q0 signal at a higher chemical 
shift did not seem to change much and remained relatively small with time 
regardless of presence of the ALP. Several signals of the Q2 metaphosphate 
speciation were also observed in the spectra. The decrease of the more negative 
signal at around -25 ppm appeared to be clearer. However, the stronger signal at 
around -22 ppm also decreased in intensity, although it was not clearly seen in the 
spectra plotted in Figure 5.4 and 5.5. The details of the phosphate speciation are 
not clear at the moment and particular signals of one speciation cannot be assigned 
yet. In a recent study by Döhler et al., the presence of both metaphosphate chains 
and rings were identified in solution containing dissolution products of the 
phosphate glasses in the 31P solution state spectra (Döhler et al., 2015). 
The presence of only a small fraction of Q1-phosphate was observed in all solution 
NMR spectra (Figures 5.4 and 5.5). This low fraction of the Q1 species indicates that 
this Q1 is likely to be terminal to the Q2-metaphosphate chains rather than the 
pyrophosphate dimer. Considering that every chain has two terminal Q1 phosphorus 
atoms, the average length of the chain can be estimated. The average chain length 
Page | 210  
 
of the Q2 species in the 50/50 mixture varies between 20 and 50, and is around 40 
and 60 in the 25/75 mixture without the ALP. However, these values are only rough 
estimation as they do not take into account presence of the Q2 ring fragments, 
which would have no terminal Q1-phosphate species. Additionally, some of the time 
points have no detectable fraction of Q1 even in the ALP-free samples (Figures 5.4 
and 5.5). 
In the presence of the ALP, the correlation between the decrease of the total Q1 and 
Q2 equated to the increase in Q0 is established in the Figures 5.7 and 5.8. Most of 
the spectra of the samples with the ALP showed no detectable presence of Q1. 
Assuming presence of both Q2 chains and rings and this indicated that the amount 
of Q2 chains substantially decreased in presence of the ALP.  
Enzymatic degradation of the P-O-P bond by the ALP is well known for the Q1 
pyrophosphate species. Based on the findings presented above it is proposed that 
the ALP cleaves the Q0 orthophosphate species from the terminal Q1 phosphate 
group of the Q2 metaphosphate linear chain. Therefore, the proportion of the Q1 
species in solution is the lowest as it is no longer available in the solution. 
The pH results in Figure 5.10 supported the results of the 31P solution NMR spectra 
in Figures 5.4 and 5.5 and also the results of the 31P solution NMR integrals in 
Figure 5.6. The lower pH in presence of the ALP could be related to the ability of the 
ALP to hydrolyse the Q2 metaphosphate chain and release more ionic phosphate 
products or groups such as the Q0-orthophosphate species. 
Accordingly, the proposed function of ALP is to hydrolyse the straight Q2-
metaphosphate chain by cleaving Q1 terminal phosphate group to release Q0 
orthophosphate. The release of Q0- orthophosphate species (PO4
3-), results in 
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apatite mineral formation. Figure 5.11 below describes the hypothesized role of the 
ALP:  
 
Figure ‎5.11 Schematic demonstration of the ALP enzyme activity in solution, 
describing the insertion of the Q
2
 metaphosphate linear chain in the active site of the 
ALP enzyme and the Q
1




There were two slightly contradicting observations reported in the published 
literature. Lorenz and Schröder reported that the ALP cleaved the Q0-
orthophosphate species from the Q2-metaphosphate species (Lorenz and Schröder, 
2001). Grover et al., however demonstrated that Q0 formed from the Q1-
pyrophosphate species in presence of the ALP (Grover et al., 2013). Our findings 
presented in this Chapter did not contradict either of the reports. Moreover, the 
results presented here delivered specific details explaining how the two 
contradictive observations from the literature can be part of the same mechanism of 
phosphate chain degradation. Our findings revealed that the terminal Q1 species 
belonging to the Q2 metaphosphate chains was hydrolysed by the ALP and 
converted into a Q0 species. 
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It is important to point out that the Q2-metaphosphate unit still exists predominantly 
in the solution NMR spectra after treatment glass mixture with ALP. This could be 
attributed to the Q2 ring structure generated by the dissolution of phosphate glass 
into the solution, which may not be hydrolysed by ALP function. 
In this study the phosphate glass of the glass mixtures was designed to work with 
the biological environment in the periodontal bony defect that is elevated with ALP 
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6.1.1 Silicate Glass: 
 
 The silicate glass Bioglass®45S5 (PerioGlas®) generates a rapid pH rise (pH 
> 8) during glass dissolution in physiological solutions. This higher alkaline 
pH can retard further glass dissolution in body fluids and subsequently inhibit 
the apatite formation. 
 The inhibition of apatite precipitation found with PerioGlas® is attributed to 
the suppression of the ion exchange process during glass dissolution. 
 The particle size of the bioactive glass powder is an essential factor for both 
the pH rise and apatite formation in buffer solutions, which may override any 
difference in the glass composition. Subsequently, the glass bioactivity is 
dominated by particles size. 
6.1.2 Silicate/Phosphate Glass Mixtures: 
 
 The high alkaline pH produced by the silicate glass can be regulated by 
using a silicate/phosphate glass mixture with fine PS for phosphate glass 
and large PS for silicate glasses. This PS selection was designed to reduce 
the high pH initially in order to inhibit the alkaline bacterial growth of 
P.gingivalis. Subsequently, this pH gradually rises to stimulate new bone 
regeneration. 
 The trend of glass mixtures pH could be programmed by changing the ratio 
of S-glass to P-glass in mixture. 
 Upon glass mixture degradation in buffer solution, the Q2 metaphosphate 
species of phosphate glass transforms into small amount of Q0 
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orthophosphate species and large amount of Q1 species as detected by solid 
state NMR spectroscopy. 
 The degree of conversion of the Q2 metaphosphate into the Q1 species and 
Q0 orthophosphate during the glass mixture dissolution is controlled by the 
composition of glass mixture.  
 The Q1 pyrophosphate species produced on degradation of the phosphate 
glass is known as an inhibitor of apatite precipitation and bone formation. 
6.1.3  Silicate/Phosphate Glass Mixtures with ALP: 
 
 ALP is known to be elevated in periodontal bony defects delivers Q0 
orthophosphate from the Q1 end group of the Q2 metaphosphate linear 
chains. The released Q0-orthophosphate ions are essential for apatite crystal 
formation. 
 There is no biomaterial used in periodontal treatment that would take into 
account the presence of elevated levels of ALP in periodontal bony defects. 
 The newly developed silicate/phosphate glass mixtures have a capacity to 
degrade in presence of ALP. Therefore, this new glass mixture can 
potentially adapt to the severity of periodontal disease. 
6.2  Suggestions for Future Work: 
 
 The current three ratios of P-glass to S-glass in the glass mixtures studied 
were 10/90, 25/75 and 50/50 by weight. It would be advantageous to study 
more ratios of P-glass to S-glass, such as 90/10, 75/25 and 60/40 and 
investigate the influence on the pH changes, ion release data and glass 
degradation. In addition the FTIR and NMR spectra could also be 
investigated.     
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 The particle size of the glass mixtures used in this study was a small particle 
size for P-glass and coarse for S-glass, which is beneficial in periodontal 
application. It would be worth considering as further studies to change the 
particle size for both P-glass and S-glass. For example, P-glass has large 
particle size and S-glass has small ones, both glasses have fine or both 
have large. This change in particle size range may alter the pH behaviour, 
the rate of glass mixtures degradation and ion release data; therefore, the 
FTIR and NMR spectra could be different. The pH profile could be different 
in terms of large particle size for P-glass and fine for S-glass. It would be 
predicted that the pH trend may illustrate dramatic increase in pH values at 
the beginning of the experiment due to the S-glass dissolution, and then 
follow by reduction in pH measurements owing to the dissolution of P-glass. 
This initial pH behaviour emerges from S-glass dissolution could be valuable 
in bone graft researches to inhibit the growth of bacteria found in this area 
such as Staphylococcus aureus. Neutral pH might be obtained if both 
glasses have fine particle size or both have large.   
 As demonstrated before in Chapter 5, the Q2-metaphosphate unit is still 
prominent in the solution NMR spectra after treatment of the glass mixture 
with ALP. It has been suggested that this can be related to the presence of 
the Q2 rings in phosphate glass structure which when released are not 
readily hydrolysed by ALP. This ring phosphate has only Q2 groups and 
does not contain Q1 end groups in its structure. Therefore, it could be 
perhaps too large to enter the active site of the enzyme and may not be 
enzymatically hydrolysed by ALP readily. Accordingly, the future work should 
investigate whether ALP can cleave the cyclic Q2 phosphates or not. This 
could be studied by using cyclic trimetaphosphate and hexametaphosphate 
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with ALP and then compare the results with the control data (without ALP) 
under the same circumstances using 31P solution state NMR spectroscopy.  
 Further work should include the co-sintering of the phosphate glass with the 
silicate glass in order to form three-dimensional amorphous porous scaffolds 
which can be used in regenerative bone grafts applications. The sintering 
process should fuse the two glasses (silicate with phosphate) without 
crystallisation occurring. The fundamental key of amorphous sintering can 
be achieved by expanding the sintering window which is defined as the 
temperature difference between the glass transition temperature and the 
onset of the crystallisation temperature. Therefore, in order to fuse the 
particles of the two glasses without crystallising, the sintering temperature 
must be above their glass transition temperature and below their onset of 
crystallisation temperature. 
 Using SEM-EDX analysis would be beneficial after immersion test to qualify 
and quantify the apatite formation on the surface of the glass mixture 
particles.   
 Cytotoxicity and bactericidal studies of the newly developed glass mixtures 
on P. gingivalis and other periodontal pathogens should be investigated in 
the future work. 
 Futuristic animal studies of the newly developed glass mixtures should also 
be investigated in order to translate this novel technology into the clinical 
trials. 
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The pH behaviour in SBF solution as a function of time of three different ratios for 
































































The FTIR spectra of studied glass mixtures with a 10/90 ratio before (untreated) and 
after immersion in SBF for different time period indicated in hours plotted as a 


















































































The FTIR spectra of studied glass mixtures with a 25/75 ratio before and after 
immersion in SBF were plotted as a function of time for: (a) SP1 mixture, (b) SP2 

















































































The FTIR spectra of studied glass mixtures with a 50/50 ratio before and after 
immersion in Tris buffer were plotted as a function of time for: (a) SP1 mixture, (b) 




















































































P MAS-NMR spectra (mas=22kHz) of studied glass mixtures with a 10/90 ratio 
before and after immersion in SBF plotted as a function of time for (a) SP1 mixture, (b) 




































































































































P MAS-NMR spectra (mas=22kHz) of studied glass mixtures with a 25/75 ratio 
before and after immersion in SBF plotted as a function of time for (a) SP1 mixture, (b) 












































































































































P MAS-NMR spectra (mas=22kHz) of studied glass mixtures with a 50/50 ratio 
before and after immersion in SBF plotted as a function of time for (a) SP1 mixture, (b) 


























































































































Phosphate – mixed Sr/Ca
mas=22kHz
(a) 
(b) 
(c) 
